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  Preface-3-
In this early part of autumn 1998, the Commission is still on the alert to ensure food
safety for consumers and beat "mad cow disease". The structural reform of its
departments begun in 1997 is almost completed. The Scientific Committees are
continuing their work unrelentingly and, in the field, the new Food and Veterinary
Office, established in Dublin, is gradually stepping up its checks and inspections.
Research proposals have been adopted and the work started. Others will follow
shortly.
Already, thanks to the measures taken, the epizootic is receding in the United Kingdom
pending total eradication. The ban on cattle products in Northern Ireland has been
partly lifted - under strict control - and there is every prospect of it being extended,
with all the necessary guarantees, to the whole of the United Kingdom. Meat
consumption has more or less returned to the levels reached in 1995, on the eve of the
crisis.
For some, the crisis is now behind us and it ought to be possible to relax the pressure.
This is not my point of view.
The findings from Portugal show in fact that non-observance of the measures
prescribed may facilitate the spread of the epizootic to new areas. Without being as
worrying, new cases are continuing to appear in other countries. Lastly, the scientific
assessment of the risks calls for the utmost caution at all stages in the chain. The
Commission therefore intends to continue with determination the action initiated in
March 1996 and to explain it to as many people as possible.
That is why, just a few weeks away from the conference on food safety that the
European Parliament and the Commission will be organising jointly at the end of
November with a view to drawing lessons from the BSE affair, I have asked the
Interdepartmental Working Party created at the very beginning of the crisis to update
the BSE Vademecum in order to take stock of the situation and inform consumers
directly about the progress made and the measures to be taken.
While, as I have often said, the "zero risk" does not exist as far as food is concerned, it
is quite certain that serious information that is as full as possible will tend to reduce the
risk and rekindle confidence. In 1996, in difficult circumstances, the BSE Vademecum
already fulfilled this role. I have no doubt that this new version will also succeed in
doing so.
Emma BONINO
Member of the Commission
Introduction
1.  The announcement by the UK authorities on 20 March 1996 that ten people in
that country had recently succumbed to a new variant of Creutzfeldt-Jakob
disease and that a link between bovine spongiform encephalopathy (BSE) and-4-
Creutzfeldt-Jakob disease (CJD) could not be ruled out triggered an
unprecedented crisis of confidence among European consumers with regard to
beef and bovine products. Since then, a flood of incomplete or even contradictory
information has helped to increase and then maintain the level of concern.
2.  In these circumstances, it seemed necessary to  inform consumers about the
situation, the state of scientific knowledge and the measures taken or planned in
the European Union to enhance consumer safety. This is the aim of the BSE
Vademecum.
3.  The Vademecum has been prepared by the Interdepartmental Working Party
(IWP) that the European Commission decided to create on 27 March 1996 to
evaluate the consequences of the crisis for consumers and to improve the
information supplied to them. It incorporates, updates and supplements two
previous versions dated 28 May 19961 and 29 November 19962 respectively.
4.  The Rapporteur of the European Parliament's Committee of Inquiry, 3 Mr Manuel
MEDINA ORTEGA, wrote about this work: … "The Commission should also be
asked to step up the current activities of the Interdepartmental Working Party,
created on the initiative of Mrs BONINO, and to ensure that its studies and
activities are followed up as widely as possible; (…) the widest possible follow-up
should also be given to the publications prepared by DG XXIV, such as the
"Guide for consumers",4 in which the latter tries to provide answers and give
guarantees in order to dispel the concern of consumers and of citizens in general
…".
Part I: What is BSE?
A.    What is bovine spongiform encephalopathy?
5.  Bovine spongiform encephalopathy (BSE) is a degenerative brain disease
affecting cattle. It is a new disease since, having occurred for the first time in the
United Kingdom in April 1985, it was officially recognised and described in
November 1986.
6.  BSE belongs to the family of  transmissible spongiform encephalopathies 5
(TSE), which in animals includes scrapie of sheep and goats, spongiform
encephalopathy of mink, encephalopathies of cats and certain wild animals raised
                                                
1  Document GIS-BSE (96) 1.7.
2  Document GIS-BSE (96) 7.5 : almost 3 000 copies distributed in the 11 languages of the Union.
3  Document FR/RR/319/319544en – EP220.544/def./A of 7/2/97, p. 41 § I.7.
4  i.e. the 2nd edition of the Vademecum.
5  Other term used in France: "transmissible subacute spongiform encephalopathies (TSSE)".-5-
in captivity, and in humans Creutzfeldt-Jakob disease (CJD). Most TSEs seem to
be sporadic.
7.  In the United Kingdom, BSE spread like wildfire and quickly became an
epidemic. Following its first occurrence in 1985, the number of animals affected
by the disease amounted to around 400 cases in 1987, then increased rapidly to
stand at more than 37 000 cases in 1992. Since then, thanks to the measures
taken, this number has been reduced by almost 90 % in five years, standing at
just over 4 300 cases in 1997.6 This downward trend ought to continue, with
some 1 500 to 2 000 cases forecast in 1998. 7 The United Kingdom has had a total
of over 175 000 cases,8 affecting more than 34 000 farms.
8.  In the other countries that have imported animals or animal feed from the
United Kingdom, the total number of cases recorded is around  800, which
represents less than 0.5% of all recorded cases of BSE. 9 In view of the low
incidence10 of the epizootic in these countries, it is difficult to speak of a recession
or spread of the disease except perhaps in Switzerland and Ireland, where, as a
result of the measures taken, it seems to be receding, and in Portugal, where its
spread in 1998 is a source of concern to the Commission.
9.  The infective agent responsible for BSE has still not been identified. However,
many things point to it being an abnormal form of protein called " prion". Prion
has exceptional characteristics, such as resistance to heat, ultraviolet and ionising
radiation and chemical disinfectants. The work carried out by Professor Stanley P.
PRUSINER on this protein in the United States earned him the Nobel Prize for
Medicine in 1997.
10.  According to the generally accepted scientific explanation, the BSE epizootic in
the United Kingdom has its roots in the recycling of contaminated cattle carcases
processed into animal feed in the form of  meat and bone meal, and in changes
made in 1981-82 in the technological processes used in the production of such
meal (reduction of drying temperatures and discontinuation of solvent defatting in
order to optimise the extraction of fats). These changes are suspected of leaving
behind a degree of infectiousness and permitting the propagation of an
                                                
6  37 280 cases in 1992, 4 334 cases in 1997, i.e. a fall of 88.4 % in 5 years.
7  1.435 cases diagnosed up to 1.9.1998.
8  175 239 cases on 34 473 farms were recorded in the United Kingdom as at 1/9/98. See Annex 4.
According to Professor John WILESMITH, 60% of dairy cow herds and 15% of nursing cow herds had
at least one case of BSE in the United Kingdom. Taking all herds together, this figure comes to just over
30%.
9  Around 75% of the cases diagnosed outside the United Kingdom have been in  Ireland (312 cases as at
1/10/98) and Switzerland (275 cases). This percentage rises to over 90% if  Portugal (151 cases)
is included. See Annex 4.
10  The incidence is the ratio between the number of cases of BSE observed and the population of
cattle aged over 2 years expressed in million head (see Annex 4).-6-
unidentified but already present rare cattle disease. Another theory, which is
losing ground nowadays, is that BSE was initially due to recycling of carcases of
sheep affected by scrapie and therefore to transmission of the scrapie agent from
sheep to cattle and then to recycling of contaminated sheep and cattle carcases.
However that may be, the responsibility of contaminated meat and bone meal put
forward from the start of the epizootic is nowadays accepted by almost all
scientists. The feeding of ruminants with ruminant proteins was therefore banned
in the United Kingdom from 1988. Some Member States followed suit at the
beginning of the '90s, with the official ban for the Community as a whole being
declared in 1994.11
11.  Other possible ways of transmission: to date, there is no formal proof that BSE
can also be transmitted either horizontally, i.e. from one animal to another, or
vertically, i.e. from cow to calf. Research was carried out over a number of years
in the United Kingdom to study both possibilities. It showed that  horizontal
transmission is not very likely. If it existed at all, it could only occur at an
extremely low rate; otherwise, the epidemic would not recede. The probability of
vertical  transmission is greater but likewise unconfirmed.12 Under these
circumstances, in order to explain the appearance of relatively many cases (over
20%) of BSE in the cattle born after the ban on using meat and bone meal 13 for
feeding ruminants, mention is made of difficulties in controlling such use and
especially the theory that these cattle were contaminated either directly through
absorption of feed containing unidentified contaminated meal or by "cross-
contamination", i.e. through accidental contamination of their food by feed for
pigs or poultry which itself might have contained contaminated meal.
Note: the theory of "sporadic" cases is also put forward by certain scientists to explain
isolated cases of BSE, such as the first case occurring in Belgium, for example.
12.  Crossing of the species barrier: in the case of BSE, transmissibility between
different animal species is the subject of a great many studies. Indeed, it has been
possible to transmit - in the laboratory  – the disease intracerebrally and orally to
                                                
11  Commission Decision 94/381/CE of 27 June 1994.
12  On 8 September 1997, the Multidisciplinary Scientific Committee (MSC/SSC) stated that, taking the
most recent - published and unpublished - scientific documentation on this issue into consideration,
there was, in its opinion, a probability of an increase in the risks of maternal transmission. The overall
order of magnitude of this increase was 5 to 15% (the confidence intervals being fixed at 95%), with,
however, an increased risk during the months before and after the date of the clinical appearance of the
disease in the mother. This effect was probably due to some form of direct maternal transmission,
although differences in genetic predisposition could not be ruled out. The MSC/SSC also supported the
theory that, in the absence of any infection via food and of any horizontal transmission, vertical
transmission cannot by itself maintain the epidemic, even with a much higher rate than currently
estimated.
13  In French, the "naifs" (nés après l’interdiction des farines); in English, the "babs" (born after ban): 37
122 cases in the United Kingdom as at 31/8/98. Diseased animals born after the ban on using meat-and-
bone meal (18/7/88) account for 21.2% of the cases of BSE reported in that country.-7-
mice and sheep in particular. In pigs it has been transmissible by intracerebral
inoculation. On the other hand, it is very important to note that certain animals
(cats, mink, monkeys and other zoo animals) seem to have contracted the disease
in natural conditions by consuming contaminated bovine material (meal or,
directly, bovine tissue).
B.    What is scrapie?
13.  Scrapie is an animal transmissible spongiform encephalopathy (TSE) affecting
sheep and goats. Known for more than 250 years, 14 this epizootic differs from
BSE through its  contagiousness from one sheep to another (horizontal
transmissibility) and from ewe to lamb (vertical transmissibility). It is found in
several Member States and in most continents. Scrapie has been a  notifiable
disease in the Member States since 1993.15
14.  Can this disease be transmitted to humans? Given the relatively high incidence
of this epizootic in many countries and the length of time it has been affecting
flocks and herds, it may be thought that, if there were contagion of humans, it
would have been recognised a long time ago. It can therefore be considered that,
on the basis of epidemiological data,  classical scrapie is not dangerous to
humans.
15.  As a result of work carried out in the United Kingdom it was established in 1996
that, experimentally, it was possible to transmit BSE to sheep via the food chain.
Some scientists therefore put forward the theory that, in that country, the scrapie
diagnosed nowadays might sometimes be a variant of the currently indetectable
BSE caused by consumption of contaminated meal. The possibility cannot in fact
be ruled out that ewes that had eaten infected meat and bone meal might be
contaminated by BSE. However, this is only a  theory, especially as sheep
consume meal less frequently and in smaller quantities than cattle do. 16
16.  Some scientists are worried about the risk that this theory might represent for
humans. They therefore recommend:
–  application of the obligation to notify cases of scrapie observed in flocks and
destruction of the diseased animals;
–  eradication of scrapie;
–  extension to sheep and goats of the measures taken against BSE, especially as
regards specified risk materials;
                                                
14  Scrapie was recognised for the first time in 1732 in the United Kingdom.
15  Council Directive 91/68/EEC of 28/1/91.
16  After being examined by the Scientific Steering Committee (SSC), this theory was confirmed in
its opinion of 24-25 September 1998, given the lack of proof to the contrary.-8-
–  extension to non-Community countries of the measures taken within the European
Union.
17.  The non-Community countries and the Member States which consider themselves
BSE-free dispute this theory and all the recommended measures arising from it.
C.    What is Creutzfeldt-Jakob disease?
18.  Creutzfeldt-Jakob disease (CJD) is a currently incurable fatal neurological
disease affecting humans. It belongs to the family of human spongiform
encephalopathies, which also includes kuru and two rare genetic diseases. It was
first identified in the 1920s and has spread worldwide, with an incidence of
around one case per million per year. It occurs in two forms: classical CJD and a
recently identified new variant, known as nv-CJD.
19.  Classical CJD can be divided into three categories: a "sporadic" form making up
90% of cases, "genetic" forms associated with genetic predisposition, and an
"iatrogenic" form linked to a medical or surgical act, e.g. grafting of contaminated
corneas or the use in the early '80s of hormones taken from human cadavers to
treat growth deficiencies in children. The "sporadic" and "genetic" forms of CJD
generally affect persons aged over 60. Patients usually die within 4 to 6 months
of the onset of the disease. On the basis of the scientific data on classical CJD
available so far, it is not possible to establish any links between the appearance of
these animal spongiform encephalopathies and the existence of particular dietary
habits, such as the consumption of animal brain.
A study was carried out on 405 patients and an equal number of controls in five
Member States (D, F, I, NL, UK) from 1993 to 1995. The results published in the
scientific journal The Lancet of 11 April 1998 confirm this lack of correlation.
20.  In 1996, the CJD Surveillance Unit in Edinburgh identified 10 cases of a form of
CJD sufficiently distinct from classical CJD to be described as a new variant. The
patients affected were all young adults whose average age was around 29
(between 19 and 41). Their disease was characterised by a relatively long
developoment (13 months on average) and by clinical signs and lesions of the
central nervous system observed on autopsy that were clearly different from the
classical forms of CJD. The scientists who studied these cases were not able to
find any predisposition (genetic or otherwise) in these patients' medical history
that could provide an explanation. The  SEAC,17 which is the United Kingdom's
BSE advisory committee, examined these cases and concluded,  on 20 March
1996, that "Although there is no direct evidence of a link on the basis of the
current data and in the absence of any credible alternative, the most likely
explanation at present is that these cases are linked to exposure to BSE before the
introduction of the ban on specified bovine offals in 1989". The UK advisory
committee's conclusion therefore created doubt about the transmissibility of the
BSE pathogenic agent to humans.
                                                
17  Spongiform Encephalopathy Advisory Committee (SEAC).-9-
Since then, 17 new cases of nv-CJD have been confirmed in the United Kingdom and
1 case in France, making a total of 28 cases to date.18
A number of suspected cases have been mentioned by the press in Belgium (2), the
Netherlands (1) and Poland (2), but have not been officially confirmed.
21.  On 2 and 3 April 1996, the  World Health Organisation  (WHO) called a
meeting of experts on BSE and nv-CJD. These experts confirmed that the most
plausible theory regarding nv-CJD was the exposure of the UK population to
BSE, but they stressed that no such link had been proved so far. They also
concluded that "the risk, if there is one, of exposure to the BSE agent in other
countries is considered lower than in the United Kingdom. Exposure to the BSE
agent in the United Kingdom was likely to have been higher before the regulations
on BSE now in force". The scientific work carried out since then has reinforced
the probability of transmission of BSE from cattle to humans.
22.  Is an epidemic of the new Creutzfeldt-Jakob disease conceivable?
In the absence of precise information on the disease, the most extreme declarations
have been made. Whereas some declared in 1996 that nv-CJD would be the AIDS of
the year 2000, others did not seem convinced of the existence of a link between BSE
and nv-CJD.
23.  On 16 September 1997, the SEAC came to the conclusion that recent research
had provided fresh scientific evidence of the similarity between the causal agent of
BSE and that of the new variant of CJD. Two days later (18.9.97), the UK
Advisory Committee on Dangerous Pathogens ( ACDP)19 concluded that the BSE
agent should henceforth be classified as a human pathogen.
24.  Uncertainty lingers, however, about the disease's possible development
mechanisms. For example, a meeting of international experts on TSE held under
the auspices of the CPMP20 considered on 15 January 1998 that transmission of
the disease by medical products derived from human blood or plasma was "very
unlikely". For their part, a group of around 50 experts meeting from 11 to 13
February 1998 at the headquarters of the WHO in Geneva thought that a sizeable
epidemic could not be ruled during the next 10 to 15 years. The new variant of
CJD might in fact prove to be more infectious than classical CJD through the
blood (blood transfusion in particular).
As regards the number of victims, it was stated at the International Conference on
Emerging Diseases held in Atlanta in March 1998 that in the United Kingdom the
number of persons affected by the new disease might be somewhere between a few
                                                
18  27 cases were officially recorded in the United Kingdom by the Department of Health up to 1998, i.e. 3
cases in 1995, 10 cases in 1996, 10 cases in 1997 and 4 cases in 1998.
19  Advisory Committee on Dangerous Pathogens (ACDP).
20  Committee for Proprietary Medicinal Products (CPMP).-10-
hundred and 80 000 cases, depending on whether the incubation period was 10 or 25
years.
25.  Conclusion : the absence of a diagnostic test and the lack of knowledge about the
incubation period for nv-CJD place the scientific community in a situation of
uncertainty that justifies the additional  cautionary and precautionary measures
taken or recommended and the efforts devoted to research by the European
Commission.
Part II: Combating BSE: what measures have been taken?
26.  As soon as the epizootic emerged in the United Kingdom in 1986, a whole host of
measures were taken to counter its development until it could be eradicated.
These measures were taken in the United Kingdom first of all, then in certain
Member States and lastly throughout the European Union.
A. Measures taken up to 27 March 1996
27.  The most important measure to protect both human and animal health, in the
United Kingdom in 1988 and in the other Member States where cases of BSE
appeared subsequently, was the slaughter and destruction of animals affected or
liable to be affected.21 Moreover, in 1988 the United Kingdom banned the use for
feeding ruminants of meat and bone meal (from ruminants) and in 1989 the use
for human consumption of certain types of  offal, such as the brain and spinal cord
from cattle aged over 6 months. This involved therefore the withdrawal from the
human and animal food chains of the materials most likely to present a risk of
transmitting the disease.
28.  Since 1988, other measures have been introduced by the British Government and
by the Community in order to prevent the spread of BSE and minimise any risk to
human health. These measures are listed in the Annexes.22 They relate mainly to
the withdrawal of specified risk materials (SRM) from the human and animal food
chains and to preventing the epizootic from spreading to the other Member States
or to non-Community countries. 23
29.  The Community measures to prevent the spread of BSE to other countries have
been successful, since less than 0.5 % of the cases have occurred outside the
United Kingdom.24 The measures taken in the United Kingdom to control the
                                                
21  In the other countries (B, F, IRL, L, NL, P), the authorities go even further and slaughter all the herd in
which a case is diagnosed.
22  See Annexes 2 and 3.
23  Since March 1990, for example, the Member States have had to no tify all cases of BSE to the
Commission and the other Member States.
24  0.43%: see Annex 4.-11-
disease - particularly the ban on feeding ruminants with infected meal - have
likewise been relatively effective, since the annual incidence of BSE fell by 90%
between 1992 and 1997 (see § 7). It seems clear, however, that this ban has not
been fully observed, since more than 20% of the recorded cases of BSE 25
occurred in animals born after the ban. Although the scientific work being carried
out reinforces the theory of vertical transmission of BSE, this theory alone does
not seem able to explain the situation.
30.  Within a few days of the announcement on  20 March, the other Member States
adopted safeguard measures against all British bovine products, especially beef.
Despite that, the consumption of beef plummeted in most Member States. After
consulting the Scientific Veterinary Committee (SVC) on 22 March, the
Commission convened a meeting of the Standing Veterinary Committee (SVC) on
25 and 26 March in order to elicit its opinion on the adoption of Community
safeguard measures. Following this consultation, the Commission adopted an
embargo decision on 27 March 1996.26
B. The ban of 27 March 1996
31.  A large number of measures were taken at European Union level. They are listed
in chronological order in the Annex. 27 The most "spectacular" measure was the
embargo decision of 27 March. Pending an overall examination of the situation, it
introduced a temporary  ban on exports from the United Kingdom to the other
Member States and non-Community countries of live cattle, their semen and
embryos, meat and products derived from cattle slaughtered in the United
Kingdom and intended for human and animal consumption, mammalian meat and
bone meal and products intended for medical, cosmetic or pharmaceutical use. In
addition, the United Kingdom was required to report to the Commission every
two weeks on the application of national and Community measures to control
BSE and asked to present further proposals for controlling BSE in that country.
32.  With the exception of milk and milk products, and certain products such as
leathers and skins, the United Kingdom could not export from its territory to the
other Member States or to non-Community countries any product obtained from
cattle slaughtered on its territory.
Contested by the British authorities, the embargo was the subject, in July 1997, of an
action against the Commission before the European Court of Justice by the British
trade union NFU.28 The Court delivered its judgment on 5 May 1998, confirming the
validity of the measure and considering that the Commission had acted in the interests
of consumers, given the seriousness of the danger.
                                                
25 Over 37 000 cases (see §11).
26  Decision 96/239/EC of 27/3/96.
27  See Annex 1.
28  National Farmers Union (NFU).-12-
33.  Milk and milk products were not affected by the Decision of 27 March 1996.
Indeed, so far, milk and milk products from animals infected with BSE have not
shown any signs of  infectiousness, and the data on other animal or human
spongiform encephalopathies tend to prove that milk does not transmit these
diseases. Milk and milk products are therefore considered to be safe, even in
regions with a high incidence of BSE.
These are the conclusions set out in the WHO communiqué 29 of 3 April 1996, which
the Commission has taken over. The Scientific Steering Committee (SSC) and the
Scientific Veterinary Committee (SVC) have confirmed this position by classifying
milk in category 4 ("no infectivity detected"). 30
34.  The same applied to products that do not enter the human or animal food chain,
such as leathers and skins (category 4).
35.  Similarly, the experiments have so far not revealed any infectiousness in  beef and
have not shown that such meat could play any sort of part in the transmission of
BSE. Moreover, the measures taken since the emergence of BSE, and especially
since 20 March 1996, have further increased the safety of meat and derived
products for health. The national and Community authorities therefore consider
that, in the United Kingdom as in the other Member States, the risks of
consumers becoming contaminated through eating beef are virtually nil. For
precautionary reasons, however, as long as all the guarantees have not been
obtained, authorisation to export beef and products derived from animals
slaughtered in Great Britain cannot be considered. 31
36.  In the case of bovine semen, the principle of lifting the ban was accepted in June
199632 because no trace of infectivity has ever been detected in this product. The
Scientific Veterinary Committee therefore considered that it was not a danger to
animal health as regards transmission of BSE. Besides, in accordance with the
provisions of Directive 88/407/EEC, 33 semen is taken only from bulls certified
healthy.
37.  Gelatine and tallow are used in the manufacture of or as ingredients in many
industrial products, such as foodstuffs, medicines or cosmetics. It was therefore
necessary to investigate whether such products can or could have been made from
a raw material infected with the BSE agent, and to assess the possible risks of
such situations.
                                                
29  World Health Organisation (WHO).
30  See Annex 10.
31  Except for meat from herds eligible for export from Northern Ireland (see §43).
32  Decision 96/362/EC of 11/6/96.
33  Council Directive 88/407/EEC of 14/6/88.-13-
In a WHO communiqué dated 3 April 1996, it was stated that "gelatine used in food is
considered to be safe if it is obtained by a manufacturing process that has been shown
to apply production conditions that make it possible to inactivate to a large extent any
residual infectivity that might have existed in the source tissue. Tallow is also
considered to be safe if effective processes for treating cadavers are used".
Two years later, in March 1998, the SSC adopted a more guarded opinion. When
gelatine or tallow are to be used as ingredients in food 34 or (in the case of gelatine) in
pharmaceutical products, the Committee recommends in particular that the raw
materials from which they have been made come from animals deemed fit for human
consumption, that specified risk materials are excluded from the production chains in
countries which are not BSE-free and that they have been produced under appropriate
technological conditions. For the United Kingdom, the SSC recommends additional
conditions.
38.  By a Decision of 16 March 1998, the Council therefore lifted the export ban for a
number of products, such as tallow and similar or derived products obtained from
cattle slaughtered in the United Kingdom under the manufacturing conditions laid
down by the Scientific Steering Committee. On the other hand, the Decision
maintains the export ban for all the other products covered by the Decision of 27
March 1996 (including gelatine).
39.  Foodstuffs, cosmetics or pharmaceutical products  whose ingredients include
gelatine,  tallow or other similar or derived products are likewise considered safe
provided the ingredients themselves are safe.
40.  Can the ban on the products covered by the Decision of 27 March 1996 be
lifted? The Commission has always considered that, in cases of doubt about the
safety of a product, this doubt should be to the benefit of the consumer.
Conversely, when scientifically a product is recognised as safe, the Commission
considers that there is no reason to oppose its manufacture and distribution under
the requisite conditions. At the  Florence summit on 21 and 22 June 1996, the
European Council confirmed this principle and envisaged the possibility of  a
gradual relaxation of the restrictions on the export of bovine products from the
United Kingdom to the rest of the European Union and to non-Community
countries. To this end, the 15 agreed on five conditions for gradual lifting of the
ban, namely:
–  withdrawal of all meat and bone meal from farms or from establishments
manufacturing animal feed;
–  stepping-up of checks in slaughterhouses;
–  introduction of a passport system for all cattle and setting-up of a computerised
system for the identification and monitoring of animals;
–  removal of cattle aged more than 30 months from the human and animal food
chains;
–  application of a selective culling programme.
                                                
34  For humans or for animals.-14-
41.  The United Kingdom took measures to fulfil the conditions agreed on and since
1996 has been sending the Commission bi-monthly reports informing it of the
measures taken and the results achieved. These show that in September 1998,
taking all the eradication plans together, more than 4 million cattle had been
slaughtered and destroyed in the United Kingdom. 35
In addition, more than 6 million 36 cattle passports have been issued.
42.  The Commission has carried out a series of inspections in the United Kingdom in
order to check the progress of the eradication and control measures.  Visits are
also made regularly to check compliance with Community legislation, especially
as regards storage of meat and bone meal not yet destroyed and the export ban.
43.  In February 1997, on the basis of the measures taken and results achieved, the
United Kingdom presented an initial proposal aimed at lifting the restrictions on
the export of cattle from herds certified as BSE-free. The Scientific Veterinary
Committee made a large number of comments about this proposal, which
prompted the United Kingdom to improve its arrangements in order to submit a
fresh proposal in July.
Moreover, during summer 1997, the confirmation by the UCLAF 37 and the FVO38 of
large-scale fraud led the United Kingdom to step up the veterinary controls in order to
prevent any export of British beef.
44.  In the wake of all the measures taken by the United Kingdom and the agreement
in principle of the "Scientific Committee for Veterinary Measures relating to
Public Health" (ex-SVC) of the European Union, and after examination by the
Standing Veterinary Committee (SVC), the Council of Agriculture Ministers
finally gave its agreement39, on 16 March 1998, to a  limited and conditional
lifting of the ban on exports from Northern Ireland (Ulster) of boneless beef
from eligible herds, i.e. free of BSE for at least eight years.
This Decision came into effect on 1 June 1998 40, i.e. on the date set by the
Commission on the basis of fresh inspections confirming the conformity of the
measures taken by the UK authorities. Every three months, the Commission will have
to revise the provisions adopted.
                                                
35  The cattle population is estimated at under 12 million head  in the United Kingdom - see Annex 12.
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37 Anti-fraud coordination unit of the European Commission.
38 Food and Veterinary Office (FVO) of DG XXIV, established in Dublin since 1997.
39  Council Decision 98/256/EC of 16/3/98.
40  Commission Decision 98/351/EC.-15-
45.  Given the number, scale and effectiveness of the measures taken by the European
Union and the United Kingdom against BSE, it is possible to envisage, in the
medium term, a partial and conditional lifting of the ban that has been affecting
meat exports from Great Britain for more than two years. To this end, the
programme proposed by the UK authorities (date based export scheme) will have
to be approved by the Commission, which will then have to submit to the
Standing Veterinary Committee (SVC) and subsequently to the Council of
Agriculture Ministers a proposal to this effect for final approval by the latter.
However, this is hardly likely to happen before the end of 1998.
C. Specified-risk materials (SRM)
46.  Importance of this issue: scientists very soon realised that certain tissues were
more likely than others to carry the infectious agent and transmit BSE. By acting
on these tissues, it seems that it is possible to reduce the risk of transmission
appreciably.
47.  From 1989, the UK authorities have banned the use of specified bovine offal in
human food and then, since 1990, in animal feed.41
48.  In April 1996, a group of experts convened by the World Health Organisation
(WHO)  recommended that no product or part of any animal whatsoever that had
shown signs of transmissible spongiform encephalopathy (TSE) be introduced
into the food chains (human or animal), and that no country allow  tissues liable
to contain the BSE agent to enter these chains.
49.  On 21 October 1996, the Scientific Veterinary Committee (SVC) of the European
Union drafted an opinion stating that the presence of scrapie could not be ruled
out in any Member State. Subsequently, while the risk linked to BSE was much
lower in the Member States other than the United Kingdom, it was nevertheless
not zero. It therefore recommended that these tissues, termed  "specified risk
materials" (SRM), be withdrawn from all the food chains (human or animal) in
the countries or regions where a potential risk had been identified and that, in the
case of cattle, sheep and goats found dead, the SRM be withdrawn so that they
could not enter the human or animal food chain or, better still, that the whole
carcase be destroyed. In the case of cattle, sheep and goats aged over 12 months,
these tissues comprised mainly at that time the brain, spinal cord and eyes, as well
as the spleen of sheep and goats.
50.  On the basis of these recommendations and opinion, the Commission drew up a
proposal for a decision aimed at banning the use of SRM from cattle, sheep or
goats in the manufacture of foodstuffs and animal feed. The proposed measures
were to be applied in all the Member States without prejudice to the stricter
measures already applied in the United Kingdom. On the other hand, provision
was made for derogations to be granted to non-Community countries.
                                                
41  See Annex 3.-16-
When it was examined by the Agriculture Council on 16 and 17 December 1996, only
five delegations (F – IRL – L – S – UK) were in favour of the proposal, while the
other ten voted against it. The decision was therefore rejected.
51.  Decision 97/534/EC of 30/7/97: in the following July, the Commission presented
a new proposal for a decision aimed at prohibiting all use of SRM in the human
and animal food chains and for the manufacture of medical, pharmaceutical and
cosmetic products. Although divided to the point of not taking a decision, the
Council was not against the Commission doing so itself, which it did on 30 July
1997.42
This Decision prohibited, from 1 January 1998, all use of SRM and introduced
measures to ban imports of products derived from or containing these tissues from
non-Community countries.
52.  In the following months, it emerged that  problems might arise with the supply of
essential pharmaceutical products that could be manufactured from these tissues
only. Moreover, Article 2 of the Decision ("all use of SRM shall be prohibited")
could be interpreted too widely. Accordingly, the placing on the Community
market of all products in which SRM are used, including car tyres, electrical
components, silicons, etc., could have been prohibited. The Commission therefore
proposed to amend the Decision by adapting it in the light of the scientific
opinions adopted in the meantime.
In order to enable the Commission to present a new proposal, it was decided to put
back the date for implementation of the Decision from 1 January to 1 April 1998.
53.  On 17 and 31 March 1998, two new proposals for Decisions presented by the
Commission were rejected in turn by the Agriculture Council, which decided to
extend to 1 January 1999 the Decision of 30 July 1997, while asking the
Commission to  present a new proposal after the general session of the
International Office of Epizootics (IOE) in May 1998.
54.  The question of SRM illustrates the difficulties sometimes facing the European
Union, the Member States and the international community.
55.  On the one hand, a certainty shared by practically everybody: the dangerousness
of specified risk materials (SRM). Moreover, certain Member States, particularly
those most directly concerned (UK, IRL, F, P, B, L, NL), have already taken
precautionary measures to protect their consumers from all risks of
contamination. For example, the United Kingdom banned the use of SRM in
human (1989) and animal (1990) food, as did France (1996), the Netherlands
(August 1997) and Belgium (March 1998). These countries approve the measures
recommended by the Commission and would like them to be applied not only by
all the Member States but also by non-Community countries not recognised as
BSE-free.
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On the other hand, opposition to the measures recommended by the Commission. In
actual fact, the Member States which consider themselves free of BSE or even TSE
approve the measures recommended by the Commission, provided that such measures
take account of the status of each country and, therefore, are not applied to
themselves.
56.  As for non-Community countries, with the exception of Switzerland, they claim
to be BSE-free and refuse to see the slightest Community constraint applied to
their exports. However, apart perhaps from Australia and New Zealand, all sheep-
rearing countries are affected by scrapie.
57.  Given the economic interests at stake and the scientific uncertainties about the
dangerousness and geographical spread of BSE, as well as the Commission's
determination to give consumers in the Union the greatest possible guarantee, the
debate on the measures to be taken is likely to divide the Member States for quite
some time yet. For their part, the Scientific Steering Committee and the IOE are
continuing their investigations on this subject. 43
D. Animal meal
58.  Very shortly after the appearance of BSE, British scientists suspected the
consumption of meat and bone meal (MBM) by cattle of being responsible for the
epizootic. That was why, as long ago as July 1988, the United Kingdom, then
certain Member States and lastly, in June 1994, the European Union (EU)
banned the use of mammalian meal for feeding ruminants . Moreover, the EU
laid down compulsory manufacturing standards in all the Member States in order
to improve the safety of meal for other animals (pigs, poultry, fish, etc.). These
standards have been tightened since 1 April 1997.44
59.  At the same time, certain consumer organisations came out against meat and bone
meal in feed for herbivores. Other organisations went even further. Following the
transmission of BSE to carnivorous animals, they called for  a ban on the
consumption of animal proteins in the form of meal for all animals of any
species whatsoever. However, while the measures taken in this area have had
beneficial effects as far as BSE is concerned, going further towards a ban on meat
and bone meal might have far-reaching ecological and economic or even health
consequences in certain countries. Before any decisions were taken in this area, it
was therefore necessary to measure the potential risks of such meal for animal
and, ultimately, human health.
60.  That was why the European Parliament and the Commission decided to organise
jointly an International Scientific Conference on Animal Meal on 1 and 2 July
1997 in Brussels. Under the aegis of the EU's Scientific Steering Committee
(SSC), the Conference's aim was to review the situation with regard to animal
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meal in order to provide the Commission and the Parliament with as much
information as possible.
The Conference enabled the issue of animal meal to be tackled with the best scientific
specialists on the subject while fostering a  wide-ranging debate with all the parties
concerned in both the Community and non-member countries.
A broad consensus was obtained on:
–  the maintenance of the ban on feeding ruminants with meat and bone meal derived
from mammals;
–  the need for a healthy supply of raw materials;
–  the use of the best available rendering and production methods.
The Conference proceedings were published in the form of a report and placed on
the Internet. This report is available from the Commission. 45
61.  Before deciding on the legislative measures to be proposed, the Commission
initiated in November 1997  a wide-ranging consultation on two fundamental
questions:
(1)  for the manufacture of meal for animal consumption, should the cadavers of
fallen animals and all materials impounded on health grounds be excluded,
using only the materials deemed fit for human consumption but which, for
commercial or technical reasons, are not used for this purpose?
(2)  should all use of animal proteins for feeding herbivores be banned?
Launched in November 1997, the consultation finished at the end of February 1998.
The Standing Veterinary Committee was informed of the findings on 5 May and the
Consumer Committee on 26 May. The latter forwarded a resolution to the
Commission46 on 17 June 1998.
The Commission is now going to decide what amendments might have to be made to
the current legislation.
62.  In the light of the results of the Conference of 1-2 July 1997, the  SSC adopted on
26-27 March 1998 an opinion on meat and bone meal derived from mammals
and intended for feeding non-ruminants (the feeding of ruminants with MBM
being banned in any event).47 The Committee recommends  inter alia that the
animals from which the raw materials are derived be fit for human consumption,
that the specified risk materials be removed if the origin of the animals is not
certified as being in a BSE-free country, and that appropriate production
processes be used, particularly the minimum standard of 133 C/20 minutes/3 bar,
                                                
45  Report on the International Scientific Conference on Animal Meal – Brussels, 1 and 2  July 1997.
46  See Annex 8.
47  See Annex 10.-19-
or an approved equivalent. For the United Kingdom, the SSC recommends a total
ban on the use of MBM derived from ruminants as feed for any mammal.
63.  In its final report to the Temporary Committee of the European Parliament on the
follow-up of recommendations on BSE (COM(97)509), the Commission
proposed that the Joint Research Centre (JRC) carry out studies on the validation
of tests to identify meat and bone meal in feedingstuffs.
The JRC has started work on validating two methods of analysis, at an international
level with the participation of all the EU Member States:
1. the first method is used to establish whether animal meal has undergone correct
heat treatment (20' at 133°C);
2. the second method is used to detect the presence of mitochondrial bovine DNA in
feedingstuffs containing less than 0.125% of MBM of bovine origin.
For both methods, the JRC is also going to prepare reference documents.
E. Traceability from the farm to the table
64.  The BSE crisis revealed a whole series of shortcomings in the monitoring of
animals, meat and derived products. It became clear, for example, that the
labelling of beef and derived products had to be improved in order to reassure
consumers about their quality and hygiene in particular.
65.  One of the main objectives of Council Directive 92/102/EEC on the identification
and registration of animals48 was to give the inspection services the means of
going back to the animal's farm of origin and tracing its movements within the
Member States. To this end, it had introduced a  system of identification and
registration of bovine animals.49 Experience showed that the implementation of
this Directive had not been satisfactory and that the system had to be improved.
The main weaknesses detected were, on the one hand, the impossibility of tracing
animals owing to the lack of recording of movements in a centralised database
and, on the other, the shortcomings of the accompanying documents.
66.  A new Regulation50 was therefore drawn up to consolidate the provisions of
Directive 92/102/EEC, through a  new system of identification and
registration. It provides for  earmarks to identify bovines individually, a central
computerised database, a passport for each animal and registers of animals on
each farm. In order to achieve effective and rapid traceability of animals, the data
on all farms situated on the Member State's territory will be recorded in the
computerised database along with the animals' identity and movements.
                                                
48  OJ No L 355,  5.12.1992, p. 32.
49  But also sheep, goats and pigs.
50  Council Regulation (EC) No 820/97 of 21 April 1997.-20-
67.  As regards the  labelling of beef and derived products, the new Regulation
consolidates the existing provisions in order to make them more effective. It
stipulates that every operator or organisation in the beef sector must submit a
specification indicating the information to appear on the label and the measure to
be taken to guarantee its accuracy. The specification must also describe the
control system to be applied and the measures to be taken with regard to
operators who do not comply with its provisions.
The specification has to establish the link between the identification of the carcase,
cuts of meat or meat-based products and the identification of the animal from which
they come.
The Regulation also mentions the information that may appear on the label. It relates
to the animal itself, especially its fattening method and its feed as well as the country
or countries where it was born, lived and was slaughtered. It is applicable
compulsorily from  1 January 2000, but the Member States have the  option of
applying it in their own country without waiting for this date.
A number have already done this (B, D, F, UK) or are on the point of doing so.
F. Research
68.  Since 1990, research on BSE has received financial support from the European
Union under the research and technological development programmes in
particular. This effort has been bolstered by the financing of 16 research projects
dealing with questions relating to CJD surveillance, the harmonisation of
neuropathological diagnostic criteria and the use of animal models to identify the
nature of the agent and the effectiveness of the species barrier.
69.  On 3 and 30 April 1996, the Council of Agriculture Ministers highlighted the need
to  intensify research on the outstanding questions concerning BSE and
welcomed the creation by the Commission of a group of scientific experts, chaired
by Professor Charles Weissmann of the University of Zurich, and the decision to
create a multidisciplinary scientific committee as soon as possible.
70.  Similarly, the Council of Health Ministers and the Council of Research Ministers,
which had met on 14 May and 5 December 1996 respectively, stressed the need
to improve cooperation and the coordination of research efforts in this area,
covering fundamental and applied biology, human and animal health, and
problems of diagnosis. This ought to result mainly in coordination of research
activities between the Member States and in calls for proposals for specific
research.
71.  The Weissmann Group was set up in April 1996 and submitted its report to the
Commission on 7 October 1996. The  Multidisciplinary Scientific Committee,
chaired by Professor Fritz Kemper, was set up on 18 June1996.-21-
Lastly, in 1997, the Commission decided to  reform its scientific research
committees, to reinforce their independence and increase the transparency of their
work, and to create a  Scientific Steering Committee (SSC) to coordinate their work.
Started in April 1997, the reform was to result by November of the same year in the
recruitment of 132 eminent scientists and the constitution of eight committees and the
Scientific Steering Committee.51
72.  In this context, taking account of the recommendations of the Weissmann
Committee and after analysing the national and Community research activities
under way, the Commission launched on 13 November 1996  a European
initiative on TSE (transmissible spongiform encephalopathies). This action plan
has two strands: coordination of activities between the Member States and a call
for proposals on  six specific research topics: clinical and epidemiological
research on human spongiform encephalopathies (SE), the infective agent and its
transmission mechanisms, diagnosis of SE, evaluation of the risk from SE,
treatment and prevention of SE, and coordination of research activities between
the Member States.
73.  A call for proposals relating to TSE was launched under the FAIR programme in
December 1996. Covering the field of BSE and animal health, it provided funding
for 8 projects relating to the development of methods for diagnosis and control
of animal TSEs.
Subsequently, a joint call under the BIOMED, BIOTECH and FAIR programmes
was issued in April 1997. It covered the six areas mentioned in the action plan on
TSE. 22 projects were selected for funding.
74.  The projects selected complement the research in progress at European and
national level in the field of TSE and constitute a coordinated effort aimed at
increasing knowledge in such important areas as:
–  identification of the agent responsible for the disease;
–  development of diagnostic methods, using tools such as magnetic resonance
imaging,  electro-encephalography or specific antibodies;
–  establishment of harmonised procedures for epidemiological surveillance of
human and animal TSE.
75.  A second joint call for proposals in the field of TSE was issued on 17 March
1998. Like the previous one, it comes under the BIOMED, BIOTECH and FAIR
Community research programmes and covers three areas of research:
–  evaluation of the risks of SE;
–  treatment of SE;
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–  coordination of national research activities between the Member States.
The closing date for submission of applications was 17 June 1998.
Twelve projects were subjected to scientific evaluation. Final selection of the projects
is now under way.
76.  Funding: On 10 November 1997, the community allocated over  50 MECU52 to
research on BSE.
One of the research topics to which the Commission attaches particular
importance is that of tests for post-mortem BSE diagnosis.
77.  The Commission has launched a project for the evaluation of a number of
available methods of post-mortem BSE diagnosis. The  Joint Research Centre
(JRC) is collaborating here, particularly as regards the handling and coding of
samples, the critical evaluation of the findings and the preparation of the final
report. It is also working on a project for electronic identification of animals
aimed at facilitating surveillance of their progression from birth to slaughter and
thereby giving consumers an additional guarantee about the origin of the animal
(March 1998).
G. Health and safety of products placed on the market
78.  The Council of Health Ministers looked at the question of transmissible
spongiform encephalopathies (TSE) on 13 December 1993, 30 April 1994 and 14
May 1996 in order to consider Germany's concerns regarding public health; they
then focused their attention on the questions of epidemiological surveillance and
the needs of scientific research.
In its conclusions, the Council recommended in particular:
–  setting up mechanisms for following up scientific evidence relating to the causes
and transmission of CJD in order to be able to determine in good time the
appropriate action to be taken to protect public health;
–  extending epidemiological surveillance of CJD to all the Member States on the
basis of the methods used by five Member States;
–  encouraging the exchange, between all Member States, of their experience as
regards control and diagnosis;
–  carrying out further studies and research on TSE, including CJD.
The Council also decided to monitor this matter on a permanent basis.
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79.  In this context, the reference made to the protection of public health in the Order
of the  Court of Justice of the European Communities of 12 July 1996 on the
"Summary procedure Agriculture-Health policy-Emergency measures against
BSE" is particularly important. According to the Court, "the circumstances show
that the Commission had, above all, regard for the protection of public health in
the context of the internal market, as moreover it is obliged to do in application of
Directives 90/425 and 89/662. It should be stressed on this point that the EC
Treaty stipulates, among the objectives of the Community, that it "shall help to
ensure a high level of protection of human health"53 and also that "the
requirements in the area of health protection shall be a component of the other
Community policies".54
80.  In the case of pharmaceutical products, the risk analysis is specific. There is a
fundamental difference here from the risk assessment for foodstuffs. For example,
products derived from tallow and gelatine are used in the composition of many
pharmaceutical products, and a number of very important medicinal products are
derived from specific risk materials (SRM). Given the beneficial effects of these
medicinal products, a derogation based on a scientific opinion may therefore be
envisaged in order to avoid any shortage of essential and vital medicines.
81.  With regard to  cosmetic products, the Scientific Committee on Cosmetology
was consulted about the safety of products derived from  tallow. The Committee
concluded that tallow products can be considered safe when clearly specified
production methods are used. The inactivation afforded by these treatment
processes is such that the exclusion of specified risk materials (SRM)  does not
seem necessary.
82.  Transparency in the working methods and decision-making procedures of the
international organisations is of the utmost importance. Improvements should
be sought. In the case of the agreement on health and phytosanitary measures, an
examination of its results and implementation will be carried out in 1998. The
Commission is determined to take advantage of this opportunity to uphold the
Community's interests in the field of food safety.
83.  Conference: in view of the importance and topicality of the issue, the European
Parliament and the European Commission have decided to organise in Brussels on
30 November and 1 December 1998 a Conference on the subject of " The
European Union and food safety: the lessons from BSE" along the same lines
as the July 1997 Conference on Animal Meal (see § 59).
H. Impact of the measures taken on trade with non-Community countries
84.  The European Union is the  world's leading trade power. It therefore has a vital
interest in ensuring that the rules of international trade are complied with.
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Accordingly, it must make sure that the legislation and procedures provide
adequate assurances to our trade partners and that our exports do not come up
against unjustified restrictions in access to the world market. That being so, the
Community must also be capable of setting the level of human health protection
that it considers appropriate. In accordance with the international rules, safety
measures must be based on scientific principles and must be backed up by
sufficient scientific evidence.
Part III: The partners: what do they want? what are they proposing?
A. Consumers
85.  Consumers' confidence in the safety of foodstuffs, especially meat, which was
badly shaken on 20 March 1996, is not yet fully restored, particularly as
fraudulent trading  of beef in Britain and the threat of having to consume
"hormonal" meat imported from the United States have jeopardised the progress
that had been made since the beginning of 1997 in this area. The Commission is
still aware, however, of the need to restore the confidence of public opinion and is
determined to continue its efforts to reassure consumers about the safety of their
food. To this end, a large-scale advertising campaign throughout the Union has
been decided by the Commission, with total funding of 33 MECU.
86.  Since 20 March 1996, the European Commission has organised quarterly
meetings of the Consumer Committee 55 and, practically every time, included the
question of BSE on the agenda in order to inform its members about the measures
taken and, in return, to get to know consumers' fears and wishes. On 9 October
1996, for example, the Committee submitted to the Commission the Resolution to
be found in the Annex.56 As can be seen from the Vademecum, several of the
proposals in this Resolution have already been approved by the Commission and
have started to be implemented.
87.  Similarly, at the International Scientific Conference on Animal Meal held in
Brussels on 1 and 2 July 1997 and the consultation which followed it, 57
consumers were able to make their wishes on this matter widely known.
Moreover, the Consumer Committee sent the Commission, on 17 June 1998, a
document setting out its position on this question 58. The Commission took note of
their point of view and that of all interested parties, with the aim of making the
necessary amendments to European legislation.
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88.  It is in fact difficult to reassure consumers. Apart from "mad cow disease", they
are very worried about food and feel themselves somehow caught in the trap of
having to consume products which, rightly or wrongly, they fear (genetically
modified organisms, hormonal meat, chocolate with modified composition,
ionised products, residues of fertilisers, pesticides, antibiotics, etc.). In an attempt
to resolve this difficulty, the Commission decided to stake everything on
transparency in scientific knowledge and information and to step up contacts
with consumer organisations in the field in order to listen to their point of view
and react to their demands.
89.  Consumers are not easily swayed, even by scientific opinions. They need hard-
and-fast proof. In keeping with the European Parliament's concerns on this point,
the Commission took the necessary steps to obtain the best scientific opinions
possible and to inform consumers by publishing all the opinions, including the
minority ones, and ensuring that such opinions are issued independently.
90.  But how can the consumer's degree of confidence or distrust in a product be
judged? The best criterion is probably that of consumption. Thus, the day after
the statement of 20 March 1996 in the House of Commons (see § 1), the sharp
fall in meat consumption in most of the Member States made it possible to gauge
the impact of the crisis that had been triggered off. This fall, which in some cases
reached 15 to 20% of normal monthly consumption, lasted for several months,
with variations from one Member State to another, before starting to turn around
from autumn 1996. In 1998, it can be estimated that,  mutatis mutandi,
consumption has returned to its 1995 level.
Is the crisis over for all that? Only the future will tell.
B. Researchers
91.  Very little is known about bovine spongiform encephalopathy (BSE) and, in
general, transmissible spongiform encephalopathies (TSE), including Creutzfeldt-
Jakob disease and its new variant, despite the many years of scientific research
devoted to them. While waiting for their work to bear fruit, scientists are
therefore forced to put forward hypotheses and, as far as recommendations are
concerned, to abide by the precautionary principle, thereby putting the
Community and national authorities in a very embarrassing position.
92.  Aware of this situation, the research centres have got together to coordinate their
work, while the national and Community authorities have increased their
budgetary resources. There is no doubt that this effort will bring results, but also
that it will be many months or even several years before the main uncertainties
surrounding this matter are dispelled.
C. Cattle-sector operators
93.  The economic consequences of the BSE crisis have been and still are quite
considerable for all cattle-sector operators. Although meat consumption has now
gone up again to its 1995 level, it is still vulnerable and extremely sensitive to any
further upheavals in the sector.-26-
94.  Not only for the cattle sector but also for the agri-food industry in general, this
crisis has clearly highlighted all the connections that may exist between the food
sector and certain areas of health, as well as in all probability the lack of
consultation structures for assessing the risks associated with technological
developments. It has also shown the sector's chronic shortcomings in terms of
communication and information.
95.  The cattle-sector operators are prepared to do everything they can to guarantee
the safety of their products. For them too, the priority is still of course consumers'
health. Already, the requirements of traceability from the farm to the table are at
the heart of their concerns in order to enhance the present arrangements and
provide the information sought by the consumer. However, in order to continue
along the right path, they need clear guidance not only from the Community or
national authorities and scientists but also from consumers, who through their
purchases make it possible for the operators to continue or redirect the efforts
already made.
Conclusion Towards a new approach to consumer policy
96.  The Commission had a hard time during the mad cow crisis. Apart from the
criticisms and even accusations levelled at the institution, it transpired that some
of its methods were unsuitable for the situation. Through its President, Mr
Jacques SANTER, addressing the European Parliament on 18 February 1997, the
Commission acknowledged the situation and announced  reforms to make its
policy and structures more suitable for handling the BSE crisis and above all to
try to avoid a repetition of such a crisis in the future.
97.  With regard to consumers, the Commission decided to pay even more heed than
in the past to their expectations, particularly in the field of food safety, by
stepping up research initiatives upstream and inspection and control activities
downstream. Through its action and even more extensive dialogue with
consumers and their organisations, and thanks to improved transparency of its
research procedures and activities, it intends to establish a  new climate of
confidence.
98.  As far as scientific research, risk analysis and assessment, and control and
inspection are concerned, the Commission presented its  new policy approach59
in April 1997.  This approach is based on a  separation of  responsibilities
between the legislative function on the one hand and scientific evaluation, control
and inspection on the other. It has resulted in a major reorganisation of the
Commission's departments.60
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The Commission also sets out here its intentions regarding the reorganisation and
operation of all the Scientific Committees. Action in the  scientific  field will
henceforth be based on the  principles of excellence, independence and
transparency.
99.  In the wake of this Communication, the Commission established on 10 June 1997
a Scientific Steering Committee 61 and created or reorganised on 23 July  eight
Scientific Committees62 for which Directorate XXIV.B provides the secretariat.
The 132 members of these new committees were nominated by a Commission
Decision of 5 November 199763 following a selection procedure including a call for
expressions of interest in which more than 800 experts took part.
100. The responsibility  for applying  Community legislation lies with the Member
States. The Commission's role is basically to check how the Member States
discharge this obligation. The system cannot work therefore unless an equivalent
level of control is guaranteed in all the Member States. Even if the inspection
services are organised differently from one Member State to another, they ought
to operate according to common standards in order to guarantee this equivalence.
In this regard, the Commission considers that the present situation is not yet
entirely satisfactory.
101. In order to improve the situation, the Commission started to apply, in 1997, a
new approach to  control and  inspection through the  Food and Veterinary
Office (FVO),64 relying on:
–  checks covering all food, animal and crop production chains;
–  formal risk-assessment procedures aimed at identifying inspection priorities;
–  systems for auditing the national inspection systems with a view to monitoring the
performance of the competent authorities and formulating the necessary
recommendations.
This task will take some time, and the Member States will be asked to adopt a
common approach from now on as regards procedures and handbooks, organisation
and operating criteria, and education and training standards.
102. Aware that there is still a lot to be done, the Commission intends to continue
along the lines of the progress achieved since March 1996, and especially since
February 1997, in order to carry out its work programme. It must be stressed,
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however, that this ambitious programme does not depend on the Commission
alone. As co-legislators, the European Parliament 65 and the Council too will have
an important part to play.
ANNEX 1
Bovine spongiform encephalopathy
CHRONOLOGY OF THE MOST SIGNIFICANT EVENTS
I.        FROM 1985 TO 1995
Sept. 1985: First identification of BSE in a cow from Pitsham, Midhurst, Sussex,
at  the Central Veterinary Laboratory in Weybridge (UK)
Nov. 1986: Formal identification of the BSE disease in a number of herds in 
England. It is thought that the first cases occurred in April 1985
June 1987: Ministries officially notified by the Weybridge laboratory (UK)
July 1988: Ban on feeding ruminants with meat and bone meal in the United 
Kingdom
1989: First cases of "mad cow disease" identified in Ireland
Dec. 1989: Ban on specified bovine offal for human consumption in the United 
Kingdom
1990: First cases of "mad cow disease" in Portugal
May 1990: After Germany, the USSR and Austria, France in turn bans imports
of British beef. The Commission demands that Germany and France,
with the support of Italy, Luxembourg and Portugal, reverse their
decision
June 1990: The bans are lifted against a promise to step up health measures
July 1990: Experimental transmission of BSE to pigs in the laboratory.  The
Lancet puts forward the theory of possible transmission to humans
Nov. 1990: Seminar organised by the European Commission: "Sub-Acute 
Spongiform Encephalopathies"
Mar. 1991: First case of “mad cow disease” in France
1992: Peak of the epizootic in the United Kingdom: 37 280 cases officially 
recorded that year
                                                
65  The Commission wishes to maintain its close cooperation with the European Parliament and
report to it twice a year on the progress made.-29-
May 1995: Death of Stephen CHURCHILL at the age of 19. He is
the first victim of the new variant of Creutzfeld-Jakob disease
II.       1996
20/3/96 Announcement by the British Secretary of State for Health, Stephen 
DORREL, of a possible link between BSE and CJD
27/3/96 Community ban on British exports of beef and derived products;
setting-up at the Commission of an Interdepartmental Working Party
on BSE; presentation of the situation to the Consumer Committee
28/3/96 Creation of a special group of experts on BSE, chaired by Prof. 
Weissmann from Zurich
2-3/4/96 Consultation of experts on BSE and nv-CJD by the WHO
22/5/96 Decision by the United Kingdom to obstruct the working of the 
European institutions in order to get the ban lifted
28/5/96 First edition of the BSE Vademecum by the Commission
18/6/96 Creation of the Multidisciplinary Scientific Committee by the 
Commission
21/6/96 European Council in Florence: the United Kingdom decided to end
its policy of obstruction adopted on 22/5/96; adoption by the Council
of a plan for gradual lifting of the ban
30/6/96 Beginning of a press campaign against the Commission in France and
then in Europe following an article published by the  Journal du 
Dimanche
5/7/96 First meeting in Brussels of the Multidisciplinary Scientific
Committee created by the Commission on 18 June
17/7/96 Setting-up by the European Parliament of a Committee of Inquiry on 
the handling of the “mad cow” crisis by the Commission
9/10/96 Conclusions of the Weissmann report: confirmation of the theory of
contamination of cattle through feed. Transmission of the disease
from livestock to humans is not proven so far. There is no evidence
that milk is a risk factor. Research is to be continued on these
matters
24/10/96 Publication in the journal Nature of research findings providing an 
initial scientific pointer to the transmissibility of BSE to humans
18/11/96 Agriculture Council: formal adoption of the plan for funding
exceptional aid to breeders suffering from the crisis on the beef
market caused by BSE-30-
29/11/96 Second edition of the BSE Vademecum by the Commission
Dec. 1996 Beginning of selective culling of cattle at risk in the United Kingdom
3-12/12/96 Committee of Inquiry: hearing of a number of personalities,
particularly Mrs Bonino, Mr Fischler, Mr Flynn and Mr Van Miert,
Members of the Commission. Mr J. Santer is himself heard on
15/1/97 in Strasbourg
III.     1997
17/1/97 Publication in the journal Science of the findings of a study by Prof. 
Dormont's team questioning the theory of transmissibility by prion
18/2/97 Speech by Mr Jacques SANTER, President of the Commission, to
the European Parliament in Strasbourg
19-20/2/97 Strasbourg: the European Parliament adopts the report of the
Committee of Inquiry and a resolution underlining the Commission's
responsibilities in the management of the BSE crisis and calling on it
to do certain things; rejection of a motion of censure against the
Commission
26/2/97 Creation of the Group of Commissioners responsible for consumers'
health, under the chairmanship of President Jacques Santer, to ensure
that the recommendations of the Parliamentary Committee of Inquiry
on BSE are followed up
11/3/97 Adoption by the Scientific Veterinary Committee of a report
concluding that there is no risk of transmission of the disease via milk
or milk products
1/4/97 Reorganisation of certain Commission departments concerned with
BSE. DG XXIV becomes the Directorate-General for “Consumer
policy and consumer health protection”
- Implementation of Commission Decision 96/449/EC on the 
minimum parameters for the processing of animal waste of 
mammalian origin
21/4/97 Traceability: the Agriculture Council adopts Regulation (EC) No
820/97 establishing a system of identification and registration of
cattle and regarding the labelling of beef and beef products
24/4/97 Creation by the European Parliament of the Temporary Committee
on the follow-up of recommendations on BSE presented in February
by the Committee of Inquiry on the “mad cow” crisis
1-2/7/97 International Scientific Conference on Animal Meal organised jointly
by the Commission and the European Parliament under the aegis of
the EU's new Scientific Steering Committee in Brussels-31-
30/7/97 Adoption by the Commission of Decision 97/534/EC defining
specified risk materials and prohibiting their use as from 1 January
1998
30/9/97 Confirmation by the Commission of the existence of exports of beef 
from the United Kingdom to Europe and non-member countries
4/11/97 Identification of the first case of “ma d cow disease” in Belgium
6/11/97 Adoption by the European Parliament of the conclusions and
recommendations of the Temporary Committee on the follow-up of
the “mad cow” crisis by 427 votes for, 33 against and 45 abstentions
Nov. 1997 Setting-up of the Commission's new Scientific Committees
2/12/97 Identification of the first case of “mad cow disease” in Luxembourg
9/12/97 Postponement from 1/1/98 to 1/4/98 of the date of application of the 
Decision of 30/7/97 on specified-risk material
16/12/97 Entry into force of the ban on consumption of beef-on-the-bone in
the United Kingdom
23/12/97 United Kingdom: opening of an inquiry on the relevance of the 
measures taken in the United Kingdom against BSE
IV.      1998
16/3/98 Decision of the Agriculture Council lifting the ban on exports of
boneless beef from Northern Ireland herds free of BSE for 8 years
31/3/98 Postponement from 1/4/98 to 1/1/99 of the date of application of the
Decision of 30/7/97 on specified  risk materials (SRM)
26/5/98 Presentation by the Commission of the first six-monthly follow-up report
on BSE to the European Parliament
29/5/98 Commission Decision to lift the ban on exports of boneless meat from
Northern Ireland herds free of BSE
10/6/98 Commission proposal to lift the ban on exports of  boneless meat
obtained from BSE-free cattle slaughtered in the United Kingdom. The
draft proposal will be submitted to the Standing Veterinary Committee.
22/7/98 Commission Recommendation to the Member States and third countries
with a view to evaluation of their epidemiological status with respect to
TSEs
25/9/98 Spain bans the entry of cattle and beef from Portugal onto its territory
(to be continued!)-32-
ANNEX 2
BSE : main measures taken by the Commission and the Council
Since bovine spongiform encephalopathy first appeared in the United Kingdom,
the Commission and the Council have taken a wide range of measures to protect
consumer health and eradicate the epizootic in the light of advances in scientific
knowledge. Below is a list of the Commission Decisions in chronological order:
–  89/469/EEC of 28 July 198966 banning the export of live cattle born before
18/7/88 or born to cows suspected of having BSE from the United Kingdom
to the other Member States. Subsequent Decisions amended or clarified this
measure until Decision 96/239/EC of 27 March 199667 ordered the provisional
cessation of all exports of live cattle, beef and derived products from the
United Kingdom to the other Member States and non-Community countries;
–  90/134/EEC of 6 March 199068 on compulsory notification of any source of
BSE;
–  90/200/EEC of 9 April 199069 requiring in particular the separate retention
and slaughtering of all  cattle suspected of having BSE, an examination of
their brain tissue to determine whether BSE was present and, on confirmation
of the disease, the destruction of their carcase and offal. The Decision also
prohibited the  export to the other Member States of certain tissues and
organs of bovine animals aged over 6 months born in the United Kingdom;
–  90/261/EEC of 8 June 199070, in particular requiring the United Kingdom to
make full use of computer records to guarantee  identification of animals;
–  91/89/EEC of 5 February 199171 making financial provision for a project
relating to the inactivation of the agents of scrapie and BSE in the United
Kingdom;
                                                
66 Decision 89/469/EEC (OJ No L225, 03.08.1989).
67 Decision 96/239/EC (OJ No L78, 28.03.1996).
68  Decision 90/134/EEC (OJ No L76/23, 22.03.90) repealed by Decision 92/450/EEC of 30.07.92 (OJ No
L248, 28.08.92).
69 Decision 90/200/EEC (OJ No L105, 25.04.1990).
70 Decision 90/261/EEC (OJ No L146, 09.06.1990).
71  Decision 91/89/EEC (OJ No L49, 22.02.91).-33-
–  94/381/EC of 27 June 199472 banning, with effect from 27 July 1994, in all
the Member States the use of proteins derived from ruminant tissue or - in the
event of difficulty of identification - from any mammalian tissue for feeding
ruminants;
–  94/382/EC of 27 June 199473 setting out the minimum conditions for the
processing of ruminant wastes so as to inactivate the BSE agents;
–  94/474/EC of 27 July 199474 regulating exports from the United Kingdom to
the other Member States of certain beef products and in particular requiring
the United Kingdom to destroy  specified offals (brain, spinal cord, thymus,
tonsils, spleen, intestines) from cattle aged over 6 months, amended by
Decision 95/287/EC of 18 July 1995;
–  96/239/EC of 27 March 199675 banning most British beef products;
–  96/362/EC of 11 June 199676 amending Decision 96/239/EC banning certain
categories of beef products;
–  96/385/EC of 24 June 199677 approving the  plan for the control and
eradication of BSE in the United Kingdom;
–  96/449/EC of 18 July 199678 on the approval of alternative heat treatment
systems for  processing animal waste with a view to the inactivation of
spongiform encephalopathy agents;
–  Directive 97/1/EC of 10 January 1997 79 relating to cosmetic products;
–  Council Regulation 820/97 of 21 April 1997 80 establishing a system for the
identification and registration of bovine animals and regarding the labelling
of beef and beef products;
                                                
72 Decision 94/381/EC (OJ No L172, 07.07.1994) amended by Decision 95/60/EC of 6.03.95 (OJ No L55,
11.03.95).
73 Decision 94/382/EC (OJ No L172, 07.07.1994) amended by Decision 95/29/EC of 18.02.95 (OJ No
L38, 18.02.95).
74 Decision 94/474/EC (OJ No L194, 29.07.1994).
75  Decision 96/239/EC (OJ No L78, 23.03.96).
76  Decision 96/362/EC (OJ No L139, 12.06.1996).
77  Decision 96/385/EC (OJ No L151, 26.06.1996).
78  Decision 96/449/EC (OJ No L184, 24.07.1996).
79  Directive 97/1/EC (OJ No L16, 18.01.97).-34-
–  97/404/EC of 10 June 199781 setting up a Scientific Steering Committee;
–  97/579/EC of 23 July 199782 setting up Scientific Committees in the field of
consumer health and food safety;
–  97/534/EC of 30 July 199783 on the prohibition of the use of  materials
presenting risks as regards transmissible spongiform encephalopathies;
–  97/582/EC of 28 August 199784 establishing a list of ingredients whose use
is prohibited in compound feeding stuffs;
–  97/735/EC of 21 October 1997 85 concerning certain protection measures with
regard to trade in certain types of mammalian animal waste;
–  Commission Directive 97/65/EC of 26 November 199786 adapting, for the
third time, to technical progress Council Directive 90/679/EEC on the
protection of workers from risks related to exposure to biological agents at
work;
–  98/139/EC of 4 February 199887 concerning  veterinary controls by the
Commission;
–  98/256/EC of the Council of 16 March 1998 88 lifting the ban on exports of
certain British beef products and certain categories of meat from cattle born
and bred in Northern Ireland;
–  98/248/EC of the Council of 31 March 1998 89 postponing to 1/1/99 the date
of application of Decision 97/534/EC of 30/7/97 on specified risk materials;
–  98/272/EC of 23 April 1998 on epidemio-surveillance for TSE;
                                                                                                                                          
80  Council Regulation 820/97 (OJ No L117, 07.05.1997) supplemented by Commission Regulations (EC)
114/97 and (EC) 2406/97.
81  Decision 97/404/EC (OJ No L169, 27.06.97).
82  Decision 97/579/EC (OJ No L237, 28.08.97).
83  Decision 97/534/EC (OJ No L216, 08.08.1997).
84  Decision 97/582/EC (OJ No L237, 28.08.97).
85  Decision 97/735/EC (OJ No L294, 28.10.1997).
86  Directive 97/65/EC (OJ No L335, 6.12.97).
87  Decision 98/139/EC (OJ No L38, 12.02.98).
88  Council Decision 98/256/EC (OJ No L113, 15.4.98).
89  Council Decision 98/248/EC (OJ No L102, 2.4.98).-35-
–  98/351/EC of 29 May 1998 setting the date on which dispatch from Northern
Ireland may commence;
–  Commission Recommendation 98/477/EC of 22 July 1998 to the Member
States and third countries with a view to evaluation of their epidemiological
status with respect to TSEs.
ANNEX 3
BSE: main measures taken by the British Government
1988 BSE made a notifiable disease; suspected and confirmed cases have to be 
culled and destroyed (21 June)
Ban on feeding ruminant protein to ruminants in Great Britain (18 July)
and Northern Ireland (28 November)
Compulsory slaughtering of suspected cattle, with compensation in Great 
Britain (8 August) and in Northern Ireland (28 November)
1989 Ban on the use of specified bovine offals in human food in England and
Wales (30 December), then in Scotland and Northern Ireland (30 January
1990)
1990 Ban on the use of specified bovine offals extended to a ll animal feed, 
including vis-à-vis the other Member States (25 September)
New requirements for livestock breeding and movement records to be kept
by farmers in Great Britain (15 October) and Northern Ireland (1 February
1991)
1991 Ban on the use as fertiliser of meat and bone meal produced from specified
bovine offals in Great Britain (6 November) and Northern Ireland (8 June
1992)
1995 Tighter controls on the keeping and presentation of records
Ban on removal of brains or eyes (the whole of the skull  becomes specified
offal)
Ban on mechanical recovery of meat from the vertebral column
1996 Ban on marketing of meat from cattle aged over 30 months (March)
Ban on the use of mammalian meat and bone meal in feed for all farm 
animals
1997 Obligation to bone all indigenous or imported meat obtained from cattle
aged over 6 months before it is sold to the consumer (16 December)-36-
1998 Public inquiry on BSE announced by the Minister of Agriculture in the 
House of Commons (22/12/97) for 31 December 1998
Reinforcement of measures concerning the use of meat and bone meal in
the preparation of fertilisers
Compulsory slaughter of sheep and goats suspected of being affected by
TSE (scrapie) and compensation of breeders.
ANNEX 4
Annual trends in BSE
in the United Kingdom and worldwide
1) Table of confirmed cases
2) GraphANNEX 4
Confirmed cases of BSE
situation at 1/10/1998
Country Up to
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World
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* imported animals
** IRL: figures including imported animals (5 in 1989, 1 in 1990, 2 in 1991 and 1992, 1 in 1994
and 1995)
(1) Statistical sources: International Office of Epizootics (IOE) and European Commission: the
cumulative figures are more or less identical up to 1997: for EC (173 804), IOE (173 862) and MAFF
(173 848)
(2) Provisional figures as at 12/10/1998
(3) 1989 (Falkland Islands: 1 case, Oman: 2) - 1993 (Canada: 1) - 1998 (Liechtenstein: 1)
Annual incidence: this criterion is more significant than the number of observed cases for the purpose of
assessing the scale of the epizootic. It represents the quotient  of the number of cases of BSE observed and
the cattle population aged over 2 years in million head. In the United Kingdom, the annual incidence
was estimated at 6 904 in 1992 and 816 in 1997. In the other countries, it was estimated in 1997 at 41.9
in Switzerland, 41.2 in Portugal, 22.4 in Ireland and 0.5 in France.Graph
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ANNEX 5
DG XXIV
Director-General : Horst REICHENBACH
Adviser : Jean-Jacques RATEAU
Assistants to the Director-General : Martin TERBERGER, Viviane HOFFMANN
Unit "Evaluation of health risks" : Arpad SOMOGYI
Directorate A - Consumer Policy
Director : Marina MANFREDI
Adviser dealing with Information society : Kenneth ROBERTS
Unit A1 - Policy development : Agne PANTELOURI
Unit A2 - Consumers' economic interests : Dieter HOFFMANN
Unit A3 - Agriculture, food products and health : Patricia BRUNKO (f.f.)
Unit A4 - Consumer safety and environment : Bernardo DELOGU
Unit A5 - Financial services : Thierry VISSOL
Directorate B - Scientific Health Opinions
Director : Bertrand CARSIN
Adviser : Walter DE KLERCK
Unit B1 - Monitoring and dissemination of scientific opinions : Walter SCHULLER
Unit B2 - Management of scientific committees I : Mercedes DE SOLA DOMINGO
Unit B3 - Management of scientific committees II : Peter WAGSTAFFE
Directorate C - Coordination of Horizontal Questions
Director : Theodius LENNON
Adviser dealing with integration of consumer policy in relation with non-member countries,
excluding PHARE) : Antoine VAN DER HAEGEN
Unit C1 - Resources and coordination : Gerard RIJSSENBEEK
Unit C2 - Legal matters : Mario-Paulo TENREIRO
Unit C3 - Development of consumer information, education and representation : Jens
NYMAND-CHRISTENSEN-41-
Unit C4 - Relations with the EP, the Council and the other institutions; liaison with the Food
and Veterinary Office (Dublin) : Jean-Marie COURTOIS
Food and Veterinary Office (Ireland)
Director : Peter PRENDERGAST
Adviser (Brussels) : Jacques GENNATAS
Quality and Planning Section : Stephen HUTCHINS
Unit 1 - Food of animal origin - Mammals : Carlo BERLINGIERI
Unit 2 - Food of animal origin - Birds and Plant Health : Saara REINIUS
Unit 3 - Food of animal origin - Fish - Food of non-animal origin : Willem PENNING
ANNEX 6
Scientific Committees of the Commission
The Scientific Committees in the field of consumer health and food safety were set up
by Commission Decision in 1997.
The Commission consults them in the cases provided for by Community legislation. It
may also consult them also on other questions of special relevance to consumer health
and food safety.
At the request of the Commission, the Scientific Committees issue scientific opinions
on questions relating to consumer health and food safety. It may also ask them to carry
out a critical examination of the risk assessment, devise new risk-assessment
procedures, draw up scientific opinions and evaluate the scientific principles.
The agendas, minutes and opinions adopted by the Scientific Committees are made
public and put on the Internet.
1. The Scientific Steering Committee (SSC)90
Chairman: Prof. Gérard PASCAL, Director of the Centre National d’Etudes 
et de Recommandations sur la Nutrition et l’Alimentation 
(CNERNA) (F)
Vice-Chairmen: - Dr Vittorio SILANO, Director-General of the Pharmaceuticals
Division, Ministry of Health, Rome (I)
- Prof. Marcel VANBELLE, Université Catholique de Louvain (B)
Direct members
Prof. Michael GIBNEY, Trinity College, Dublin (IRL)
Dr Philip JAMES, Rowett Research Institute, Aberdeen (UK)
                                                
90  Commission Decision 97/404/EC of 10/6/97.-42-
Prof. Werner KLEIN, Schmallenberg (D)
Prof. Robert KROES, University of Utrecht (NL)
Dr Martin WIERUP, Animal Health Service, Stockholm (S)
Chairmen of the eight Scientific Committees (below)
Ing. Georges BORIES, INRA, Toulouse (F)
Prof. James W. BRIDGES, University of Surrey (UK)
Dr Fulgencio GARRIDO-ABELLAN, Santa Fe (E)
Dr Keith M. JONES, Medical Control Agency, London (UK)
Prof. Fritz KEMPER, University of Münster (D)
Dr Ib KNUDSEN, Institute of Toxicology, Soborg (DK)
Prof. Albert OSTERHAUS, Erasmus Universiteit, Rotterdam (NL)
Prof. Antonio SILVA FERNANDES, Instituto Superior de Agronomia, Lisbon (P)
2. The eight Scientific Committees91
–  Scientific Committee on Food (Dr Ib KNUDSEN),
–  Scientific Committee on Animal Nutrition (Ing. Georges BORIES),
–  Scientific Committee on Animal Health and Animal Welfare (Dr Fulgencio
GARRIDO-ABELLAN),
–  Scientific Committee on Veterinary Measures relating to Public Health (Prof. Albert
OSTERHAUS),
–  Scientific Committee on Plants (Prof. Antonio SILVA FERNANDES),
–  Scientific Committee on Cosmetic Products and Non-Food Products (Prof. Fritz
KEMPER),
–  Scientific Committee on Medicinal Products and Medical Devices (Dr Keith M.
JONES),
–  Scientific Committee on Toxicity, Ecotoxicity and the Environment (Prof. James W.
BRIDGES)
3. Ad hoc Group TSE/BSE
–  Herbert BUDKA, Neurologisches Institut, Vienna (A)
–  Dominique DORMONT, Commissariat à l’Energie Atomique (F)
–  Michael GIBNEY, Trinity College, Dublin (IRL)
–  Philip JAMES, Rowett Research Institute, Aberdeen (UK)
–  Hans KRETZSCHMAR , Universität Göttingen (D)
–  MALMFORS, Malmfors Consulting AB, Stockholm (S)
–  Albert OSTERHAUS, Erasmus Universiteit, Rotterdam (NL)
–  Gianfranco PIVA, Ist. di Scienze degli Alimenti e della Nutrizione, Piacenza (I)
–  Josef SCHLATTER, Swiss Federal Office of Public Health, Univ. Zürich (CH)
–  Marcel VANBELLE, Université Catholique de Louvain (B)
–  Emmanuel VANOPDENBOSCH, VAR, Brussels (B)
–  Philippe VERGER, CNERNA, Paris (F)
–  Preben WILLEBERG, Veterinary and Agricultural Univ., Frederiksberg (DK)
                                                
91  Commission Decision 97/579/EC of 23/7/97.-43-
4. For information: this report also mentions the  Multidisciplinary Scientiifc
Committee (MSC), which was created in June 1996 and operated until November
1997.
Chairman: Fritz KEMPER, University of Münster (D)
Members: Dominique DORMONT, Commissariat à l'énergie atomique (F)
Gérard PASCAL, CNERNA (F)
Maurizio POCCHIARI, University of Rome (I)
Giuseppe VICARI, University of Rome (I)
Robert WILL, National CJD Surveillance Unit, Edinburgh (UK)
Preben WILLEBERG, University of Copenhagen (DK)
DG XXIV provides the secretariat for the Scientific Committees mentioned in the
previous paragraphs.
5. Other committees: there are other Scientific Committees whose secretariat is
provided by other DGs, such as:
DG III:
–  Scientific Committees of the European Agency for the Evaluation of Medicinal
Products:
–  Committee for Proprietary Medicinal Products and
–  Committee for Veterinary Medicinal Products
DG V:
–  Group of government scientific experts on the protection of health from risks
relating to biological agents at work
DG VI:
–  Standing Committee on Agricultural Research
–  Scientific Committee on designations of origin, geographical ascriptions and
certificates of specificity
–  Scientific and Technical Committee of the Community Fund for tobacco
research and information
DG XII:
–  Scientific and Technical Committee
ANNEX 7
Consumer Committee Resolution on BSE (9 October 1996)-44-
1. The Consumer Committee welcomes the Commission's efforts to improve 
consumer information about the background and the current situation 
regarding the BSE issue. The members of the Consumer Committee took 
note of the Vademecum on bovine spongi form encephalopathy (BSE).
2. For consumer organisations public health and food safety issues must be
the top priority.
3. Consumer organisations have argued from the beginning of the crisis in the
late 1980s for a precautionary approach to the consumer health and safety
issues involved.
Enforcement and inspection
￿ Consumer organisations stress the importance of the enforcement of all the
rules and controls  on slaughterhouses and farms. The safety of beef
depends on the implementation of these controls.
￿ Resources and levels of inspection by national meat hygiene services must
be adjusted to current requirements and, if necessary, increased with regard
to BSE and the potential risk to human health.
￿ National control systems of procedures in slaughterhouse s and meat-
processing industries must be subject to  monitoring at EU level,  with
publication of the results of the monitoring exercises.
￿ There should be more random inspections by  EU appointed vets of
standards in slaughterhouses throughout the EU.
Animal feedstuffs and ruminant material
￿ Consumers believe that it is fundamental for the eradication of BSE that all
animal waste of mammalian origin in the Community should be processed
by a method that has been demonstrated as being de facto effective for the
inactivation of the agents of scrapie. This requirement is laid down in
Commission Directive 96/449/EC of 18 July 1996, which shall apply from
1 April 1997. We urge the Commission to provide guarantees regarding
compliance with this Decision from that date.
￿ In addition to the existing EU ban on the feeding of meat and bone meal
derived from mammalian tissues to ruminant species, consumers request
that no ruminant should be fed with feed containing animal protein.
￿ The EU should take steps to recall  residual stocks of feed that might
contain meat and bone meal originating from BSE-infected animals, both
within the EU and from third countries. Stocks should be destroyed in such
a way that they cannot re-enter the food chain.
￿ There should be EU legislation to oblige feed manufacturers to  declare all 
the ingredients of animal feeds.-45-
Levels and detection of tracing
￿ Consumers request the full implementation of Directive 92/102 on the
identification and registration of animals, and assurance of the
traceability of any  movement of individual cattle both nationally and
across frontiers.
￿ Systems assuring that  meat is traceable "from the table" to the
slaughterhouse should be introduced.
￿ There should be an EU-wide training programme enable veterinarians and
farmers to recognise the symptoms of BSE.
Research
￿ Funds allocated to independent research, concerning the underlying causes
of BSE, the possibility of transmission to other animals and to humans and
the process of transmission, should be increased.
￿ The top research priority must be to develop a  test for BSE which can be
carried out on live animals. If and when a live test is developed, an
extensive EU-wide test programme should be put into operation as soon as
possible.
￿ Part of the funds could also be allocated to the development of a reliable
system of epidemiological monitoring of BSE and to the collection of
reliable statistical data of cases.
Labelling
￿ There should be a system of labelling for meat and meat products which
makes clear what type of meat and from what type of animal is present in
foods (e.g. lamb's liver). Such a system should also allow for  country of
origin labelling for beef and beef products marketed to consumers.
￿ Manufacturers should be required to declare the use of any  mechanically
recovered meat (MRM), even below 25% of the product.
￿ EU-wide definitions of both meat and MRM are needed to prevent
consumers from being misled.
Product liability
￿ The 1985 EU product liability Directive excludes liability for  primary
agricultural produce. It should be amended to cover primary agricultural
produce in order to raise standards.
Lack of public information
￿ We consider that the growth of panic on the European beef market and the
loss of consumer confidence are largely due to a lack of information, or-46-
partial or contradictory information. This is why consumers should be
assured of the publication of the results of research and of a complete
transparency with regard to the scientific elements on which the
Community bases its decisions.
￿ We believe that consumers should be given correct, complete and
transparent information to enable them  to make an informed choice.
￿ One possibility could be the creation at EU level of an  information office
responsible for circulating data forwarded by the national sanitary
authorities.
Risk assessment
￿ As long as there are no definitive scientific results, the precautionary
principle should apply. This means that measures to cope with a risk must
be based not only on solid scientific evidence but also on the existence of
valid scientific questions that have not yet been definitively answered.
Measures for the protection of human health must be designed to achieve
the highest possible level of protection.
Consumer representation
￿ Consumers ask the Commission to promote consumer representation  on
all scientific and advisory committees at EU level .
EU food policy and production methods
￿ The BSE crisis stresses the consequences of an economic policy the
objective of which is intensive productivity.
￿ One contributing factor to the current crisis has been a lack of regard for
consumers' preferences, expectations and emotions in relation to food.
Policy-makers have tended to dismiss these preferences and expectations
unless they can be proved to be fully rational and based on scientific
evidence. Issues such as origin, production methods, processing and
previous history of food can influence consumer attitudes, yet current EU
food policy tends to ignore the legitimacy of  consumer concerns on these
issues.
￿ We call therefore for an urgent review of food policy (and in particular of
food production and distribution) in order to meet more closely the
expectations and preferences of consumers. On 29/30 April 1996, the
Agriculture Council agreed that a long-term solution (to the current crisis)
requires, inter alia, "production techniques which correspond to the
legitimate expectations of consumers...". This conclusion should be
followed up immediately with practical action.
ANNEX 8-47-
Consumer Committee Resolution on meat-and-bone meal
(17 June 1998)
The Consumer Committee welcomes the Commission's consultation paper on
meat and bone meal and is happy to answer the following questions.
1. Exclusion of fallen animals and all condemned meat from the feed
chain
The Consumer Committee supports the exclusion of fallen animals and all 
condemned material from the feed chain.
The Consumer Committee considers that this exclusion would further
reduce the risk of:
- disease transmission;
- contamination of pasture land and water which might arise from
dumping animal waste in land-fill sites;
- unacceptably high levels of residues within animal feed.
It would also answer many ethical concerns and objections to feeding
animals on cadavers.
The Consumer Committee considers that more research is needed into the
health risks attached to the various alternative disposal options to rendering.
There must be effective monitoring and inspection of whatever method is chosen.
This must be backed up by random inspections carried out by EU veterinary,
medical and environmental officials.
2. Ban on the use of all animal protein in the feeding of ruminants
The Consumer Committee supports the EU ban on the use of all animal
protein in the feeding of ruminants as a precautionary measure of consumer
safety.
However, considering the need to have high-protein feed in certain
production systems, particularly where it is needed for animal welfare reasons, the
Consumer Committee calls for urgent research to be undertaken to find
alternatives.
Once the ban is in place, there must be a European-wide compulsory recall
of residual stocks of feed containing animal protein, followed by their destruction
so that stocks cannot re-enter the food chain.
ANNEX 9-48-
European Parliament Resolution on the report of the Temporary Committee
instructed to follow up the recommendations on BSE92
The European Parliament,
–  having regard to the report of the Temporary Committee of Inquiry into BSE
of  7 February 1997 (A4-0020/97),
–  having regard to the mandate given to the Temporary Committee instructed to
follow up the recommendations on BSE on 23 April 1997, 93
–  having regard to the report of the Temporary Committee instructed to follow
up the recommendations on BSE (A4-0362/97),
–  having regard to the Council and Commission answers given on 18 November
1997 to the oral questions on this subject,
(1)  Endorses the conclusions and recommendations of the Temporary
Committee instructed to follow up the recommendations on BSE,
especially as regards the implementation of its recommendations by the
Commission, as well as the shortcomings and non-implementation which
still exist;
(2)  Instructs its standing committees to monitor, according to their respective
competences, the future implementation of the recommendations of the
Temporary Committee of Inquiry into BSE by the Commission, based on
the half-yearly progress reports the Commission has promised to present;
(3)  Notes with satisfaction that the work of the Temporary Committee of
Inquiry into BSE and the Temporary Committee instructed to follow up
the recommendations on BSE has given a new quality to its institutional
position with respect to the Commission, thereby facilitating effective
control of the executive branch, and expects that the Commission will
continue with the collaboration it has provided in the field of BSE and will
extend it to other areas of its activities;
(4)  Welcomes the fact that the report of the Committee of Inquiry into BSE
and the setting up of the Temporary Committee instructed to follow up
the recommendations on BSE have led to the Commission taking
considerable steps toward making the action to combat BSE transparent
through information measures, both as regards the inspection reports and
the transparency of the work of the scientific committees;
                                                
92  Text adopted at the plenary sitting on Wednesday 19/11/1997.
93  OJ C 150, 19.5.1997, p. 9.-49-
(5)  Expects the Commission in future consistently to exploit any leeway for
interpretation with regard to application of the appropriate legal basis in
favour of the geatest possible involvement of Parliament and requests the
Commission to insist together with Parliament, during the next
Intergovernmental Conference, on full co-decision power for all sectors of
the common agricultural policy;
(6)  Asks the Commission and the Member States concerned, in the light of the
recent results of scientific research proving the close link between BSE
and nv-CJD, to provide rapidly and in a non-bureaucratic way the financial
means to demonstrate solidarity with the families of nv-CJD victims;
(7)  Criticises the Commission for having refused to take any disciplinary
measures in the context of the handling of the BSE crisis by Commission
departments and insists that the promise made by the President of the
Commission to change the Staff Regulations before 1999 in order to allow
more flexible use of disciplinary measures should be fulfilled;
(8)  Is in favour of organising a joint conference with the Commission at the
end of 1998 in order to check those recommendations not implemented by
then and to evaluate the consequences of the BSE crisis as regards
Community legislation and full legislative control over agricultural policy,
veterinary inspections and food safety, on the basis of the requests of its
Temporary Committee of Inquiry;
(9)  Requests the Council to make a binding declaration to the effect that
Article 3 (2) of the Decision of the European Parliament, the Council and
the Commission of 19 April 1995 on the detailed provisions governing the
exercise of the European Parliament's right of inquiry 94 will in future be
interpreted by all members of the Council in such a way that a Member
State's government is required to send one of its members to appear
before a committee of inquiry of the European Parliament at the
committee's request;
(10)  Instructs its President to forward this Resolution to the Council, the
Commission and the governments and parliaments of the Member States.
Resolution passed by the European Parliament at the plenary sitting on 19/11/97
by:
427 votes for
  33 votes against
  45 abstentions.
                                                
94  OJ L 113, 19.5.1995, p. 2.-50-
ANNEX 10
Specified risk materials (SRM)
Opinion of the SSC on the risk of BSE, adopted by the Scientific Steering
Committee (SSC) at its plenary meeting on 26-27 March 1998
After public consultation on the preliminary opinion adopted
on 19-20 February 1998
In its study of the risk of BSE, the SSC identified three main points:
1. the risk of human exposure due to direct consumption of potentially
infectious materials;
2. the risk to humans arising from ingestion of processed potentially
infectious materials (tallow or gelatine, for example) or from exposure to
such materials, and
3. the risk of propagation of the infection by recycling of the infectious
material in animal feed (meat and bone meal).
A key factor in the study of these three risks is the relative infectivity of the
tissues of an infected animal. By excluding the most infectious tissues from the
processing cycle, it is possible to reduce the risk of transmission of BSE
considerably. This position is confirmed by recent data which make it possible to
quantify the contribution of the most infectious tissues to the total infectious
burden of an infected animal (see Table 1).
Table 1: Relative infectivity of specified risk materials from an infected animal
(data supplied by the SEAC, February 1998)
Tissue Density of infectivity
(CoID50/g)1
Weight (kg) per
animal of 537 kg
ID50 per
animal
% of total
infectious burden
per animal
Brain 10 0.5 5000 64.0
Spinal cord 10 0.2 2000 25.6
Trigeminal lymph
glands
10 0.02 200 2.6
Spinal lymph glands 10 0.03 300 3.8
Ileum 3.2*10
-2 0.8 256 3.3
Vertebral column 3.2*10
-3 5.0 16 0.2
Spleen 3.2*10
-3 0.8 3 0.04-51-
Eyes and rest of head 3.2*10
-3 11.6 37 0.5
1 CoID50 = Cattle oral Infectious Dose 50%
The SSC confirmed the list of SRM which it presented on 9 December 1997 on the
basis of infectivity, but stated that, with appropriate slaughtering procedures, the lungs
are not contaminated and can therefore be excluded from this list. Similarly, the SSC is
convinced that it is possible to define practical slaughterhouse procedures for
separating the ileum from the other parts of the intestine. If such procedures are
guaranteed, only the ileum is to be regarded as infectious.
As regards the importance of the animal species, the SSC reaffirmed its conclusions to
the effect that it is impossible to estimate the risk of BSE in sheep and goats, although
no case of TSE caused by the BSE agent has been detected in small ruminants, other
than in experiments. It therefore reiterates its conclusion of 9 December 1997 that the
head and spinal cord of sheep and goats have to be removed for animals aged over 1
year and the ileum and spleen have to be discarded whatever the age of the animal.
However, in order to confirm this conclusion, the risk of the probability of the
presence of BSE in sheep and goats should be assessed. This requires data which the
SSC does not have at present.
1. Human exposure through direct consumption
With regard to human exposure through direct consumption, the SSC acknowledged
that a list of SRM must take account of their specific infectivity and the total weight of
the various tissues (see Table 1).
On the basis of quantitative data, the SSC declared that the brain, spinal cord, spinal
lymph glands and trigeminal lymph glands represent the main risks for direct
consumption by humans. They might make up as much as 96% of the infective burden
from an infected animal, entering the food chain during the last nine months before the
clinical manifestation of the disease (youngest animal ever found: 20 months). The
animal's age therefore affects the risk of infectivity too. That is why the SSC reaffirms
its opinion of 9 December 1997, according to which the SRM have to be eliminated in
animals aged over 12 months in countries which are not BSE-free or where the risk is
not negligible.
Mechanically recovered meat too may constitute a risk material, since it may contain
spinal lymph glands.
2. Human exposure via processed products (tallow and gelatine)
With regard to the risk presented by tallow and gelatine, the SSC has issued two
opinions on the safety of these two products. It stresses that these opinions are based
on an assessment of the risks aimed at achieving the lowest possible risk. It will
supplement these opinions with a quantitative risk assessment once it has the necessary
data.
3. Propagation of the disease via the food chain-52-
On the subject of the risks presented by meat and bone meal, the SSC has adopted an
opinion on the safety of such meal. It stresses that this opinion is based on an
assessment of the risks aimed at achieving the lowest possible risk. It will supplement
this opinion with a quantitative risk assessment once it has the necessary data.
4. Origin of the animals
The geographical origin of the animals has been studied very closely at three different
levels:
•  the risk of an infectious animal entering the food chain (risk of incidence);
•  the risk of an infectious animal propagating the disease by entering the food chain
(risk of propagation), and
•  the risk for humans of exposure to an infectious dose of BSE (risk of human
exposure).
Examination of the dossiers already sent by some countries shows clearly that the data
currently available are not enough to classify these countries with any certainty. With a
view to obtaining the necessary data, the SSC approves the list of requisite data
presented in its final opinion on the content of a "request for recognition of
epidemiological status with respect to TSE", adopted on 20 February 1998.
At this stage, the SSC is not able to issue a definitive opinion on the geographical
categories. It will re-examine this point and will also devise a methodology for
evaluating the data sent by the countries on this subject.
Category Organs
1. High degree of
infectivity
a) Brain of bovines, eyes, spinal cord and spinal lymph glands of bovines,
dura mater
1,2, pituitary gland
1,2 , skull
2,3 and vertebral column of bovines
2, lungs
5
b)  Brain of sheep/goats, eyes and spinal cord, spinal lymph glands and
vertebral column
2, spleen of sheep and goats
4,lungs
5
2. Medium degree of
infectivity
a) Whole intestine, from the duodenum to the rectum
6, tonsils
b)  Spleen of bovines, placenta, uterus, foetal tissue
7,
     adrenals, cerebro-spinal fluid, lymph glands
3. Low degree of
infectivity
Liver, pancreas, thymus, bone marrow, other bones
8,
 nasal mucosa,
peripheral nerves
4. No infectivity
detected
9
Skeletal muscle, heart, kidneys, colostrum, milk, separated adipose
tissues
10,
 salivary gland, saliva, thyroid, mammary gland, ovaries,
testicles, seminal gland, other bones, cartilage tissues, connective
tissue, skin, hair, blood clot
11, serum
11, urine, bile, faeces
Notes
When the species is not stated, the tissues mentioned are those from cattle, sheep and goats.
1. These tissues are included because the human iatrogenic form of CJD has been associated with human 
tissues or extracts contaminated by the CJD agent.-53-
2. These tissues have been placed in one, two or three higher categories on account of the risk of
contamination by tissues with a higher degree of infectivity during slaughtering and the fact that they
contain spinal lymph glands. The spinal cord of sheep and goats, the spinal lymph glands and the spinal
column have been classified in this subdivision because they might be infected or contaminated whenever
sheep or goats might have been infected by the BSE agent through ingesting infectious bovine products
introduced into their feed.
3. Definition of the skull: the whole of the head apart from the tongue.
4. The spleen of sheep is included on account of the discovery of the BSE agent in the spleen of sheep
contaminated experimentally by large doses of BSE. The degree of infectivity by the BSE agent has not
been tested in goats, but infectivity from scrapie has been observed in these animals. The spleen of cattle
has been tested, and no infectivity was observed in the test carried out on mice.
5. The lungs should be included in this category if the methods of stunning or neck stabbing used during
slaughter involve a transfer of brain into the lungs via the blood.
6. Concerns only cattle, unless sheep and goats are deemed infected by the BSE agent. If so, the lymph
glands and the thymus should also be removed.
7. It would be best to include them in the same category as the placenta on account of the high probability 
of contamination during the removal of the placenta on slaughter.
8. In view of the possible presence of spinal cord in the long bones and taking account of a potential
infectivity of older animals, these bones should be classified in the same category as the spinal cord.
9. All the substances listed in category 4 were tested in mice with samples corresponding to 0.01- 0.1 g of
the initial infectious tissue. In these samples, a degree of infectivity 1 000 times lower than in the brain is
undetectable by this method. The sensitivity of this method ought to be further improved, which may
entail a revision of the above table of relative infectivity.
10. This new term is used to describe the reserves of fat that can be easily removed during slaughter in
slaughterhouses or cutting shops. It does not apply to the lipids extracted from mechanically recovered
meat or from many other tissues or, subsequently, during the production process. It involves removal of
the associated lymph glands.
11. Non-conclusive evidence suggests that the mononuclear globules of the peripheral circulation might
transmit nv-CJD.
Extract from the opinion of the SSC on meat and bone meal
Synoptic table: criteria to be met to ensure a sufficient degree of safety of meat
and bone meal produced from mammals and enable it to be introduced into the
feed of non-ruminants
Geographical origin of the animals Criteria to be met
NON-EXISTENT OR NEGLIGIBLE RISK
OF BSE
–  Material whose origin in regions where the
risk of BSE is considered non-existent or
negligible is certified.
–  Animals certified fit for human
consumption.
–  Production processes complying with the
standards laid down (133°C/20'/3 bar) or
equivalent conditions for the
inactivation/elimination of the BSE or scrapie-54-
agent.
–  Regarding continuous or discontinuous
processes: see section 3.1.
 LOW RISK –  Certified fit for human consumption.
1
–  Exclusion of specified-risk materials.
2
–  Production processes complying with the
standards laid down (133°C/20'/3 bar) or
equivalent conditions for the
inactivation/elimination of the BSE or scrapie
agent.
–  Measures designed to prevent cross-
contamination.
HIGH RISK –  No meat and bone meal intended for feeding
mammals should be produced from ruminants.
STATUS UNKNOWN To be evaluated; if it is not possible to give an
opinion on the basis of the available evidence or
owing to the lack of information: to be regarded
as high-risk.
3
1 Fit for consumption means here that the animal must satisfy all the provisions of the appropriate
and relevant national and European legislation.
2 The term "SRM or specified risk materials" applies to all the tissues on the list given in the
opinion of the Scientific Steering Committee (SSC) adopted on 9 December 1997 and amended on 19 and
20 February 1998. However, the SSC intends to examine the possibility of selecting specified risk
materials on the basis of the results of the risk assessment, taking account of the animals' geographical
origin, species and age.
3 This statement does not prejudge the SSC's opinion on the TSE/BSE status of any country.55
ANNEX 11
Estimate of the budget costs for Chapter 21
«Beef and veal» arising from the BSE crisis
1996(1) 1997 1998 1999 1996-1999
Market measures
linked to BSE actual
Mio Ecu
Actual
Mio Ecu
estimate
Mio Ecu
estimate
Mio Ecu
total cost Actual mid-
March ’98
tonnes/animals
Direct measures
Intervention
/Storage
   Aid to private
storage for veal (NL,
I, …)
9 9 18 12.000 T
   Additional costs of
intervention
315 272 106 693 693 000 t bought
since March 96, of
which 2/3 due to
BSE
Slaughtering
measures
   Processing
premium, newborn
male calves
24 122 115 24 285 1 630 000
   Premium for early
slaughtering of
calves
56 105 37 198 2 100 000
   Programme of
voluntary
slaughtering in UK
224 300 197 331 1 052 2 200 000
   Compulsory
selective slaughtering
in UK, P, F, IRL, D
27 12 76 10 125 95 000
   Destruction of
fattening calves of
UK origin (in F and
NL)
52 52 120 000
Support for the
sector /losses of
income
815 495 1 310
Cost of direct
measures
1 466 1 266 599 402 3 733
Improvement of
certain premium
systems
   Modification
special system « male
cattle » (single
premium)
53 49 102
   Prolongation
deseasonalisation
premium in IRL and
Northern IRL
37 38 36 111
   Intensification
premium (reinforced
incentive)
144 166 310
Cost of
improvement of
certain premium
systems
37 235 251 523
TOTAL BUDGET
COSTS
1 466 1 303 839 653 4 246
(1) Including expenditure on deferred appropriations56
ANNEX 12
SLAUGHTERING PROGRAMMES IN THE UNITED KINGDOM
Programme Dates (1) Number (2)
OTMS  (3)
CPAS   (4)
SC        (5)
from 29/4/97 to 13/9/98
from 22/4/96 to 11/9/98
from 22/2/97 to 13/9/98
2 512 512
1 413 936
     73 956
Total                   At 11-13/9/98 4 000 404
The animals slaughtered under these three programmes did not enter the human or
animal food chain. Their carcases were in fact destroyed.
Source: BSE Enforcement Bulletin No 26 (Sept. 1998) of the MAFF
(1) dates of implementation of the programmes
(2) number of cattle slaughtered
(3) over thirty month slaughter scheme (OTMS)
(4) calf processing aid scheme (CPAS)
(5) selection cull57
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CONSUMER COMMITTEE OF THE EUROPEAN COMMISSION
List of members (20)
GERMANY Herr Dirk KLASEN
Arbeitsgemeinschaft der Verbraucherverbände e.V.
AUSTRIA  Herr Hannes SPITALSKY
Verein für Konsumenteninformation
BELGIUM Monsieur S. MAUCQ
Test-Achats
DENMARK Hr. Peter NEDERGAARD
Forbrugerrådet
Danish Consumer Council
SPAIN D. Francisco Javier ANGELINA
Vice-Presidente Consejo de Consumidores y Usuarios
FINLAND Mrs Sinikka TURUNEN
The Finnish Consumers' Association
FRANCE M. Gérard MONTANT
INDECOSA-CGT
(Association pour l'Information et la Défense des
Consommateurs Salariés)
GREECE Mr Sotirios PASCHALIDIS
KEPKA
IRELAND Mr Peter DARGAN
Irish Countrywomen's Association
ITALY Sig. Vincenzo DONA
Unione Nazionale Consumatori
LUXEMBOURG M. Aloyse SCHMITZ
Union Luxembourgeoise des Consommateurs
NETHERLANDS Mr Koos ANDERSON
Consumentenbond
PORTUGAL Dra. Elisa RAMOS DAMIÃO
União Geral de Consumidores59
UNITED KINGDOM Mrs Anne DALTROP
SWEDEN Mrs Maicen EKMAN
Swedish Consumer Council
The following five organisations are also members of the Consumer Committee:
EBCU – European Bureau of Consumers' Unions
Director: Mr Jim MURRAY
IEIC – European Interregional Institute for Consumer Affairs
Director: Mme Mireille LEROY
COFACE – Confédération des organisations familiales de la Communauté
européenne
Director of Studies: M. Noël MOLISSE
CES – "Euro-C" – ETUC
Trade Union Confederation
Ms Anna CIAPERONI
EURO-COOP – European Community of Consumer Cooperatives
General Secretary: Mme Caroline NAETT
ANNEX 15
Scientific opinions on BSE adopted by the Commission's Scientific Committees
since November 1997 (status: 1.10.98)
Internet address: http://europa.en.int/comm/dg24/health/sc/index en.html
Scientific Committee Date of adoption Title of opinion adopted
1. Scientific Steering Committee 9 December 1997 Listing of Specified Risk Materials: a
scheme for assessing relative risks to man
2.                " " Report on the UK Date Based Export
Scheme and the UK proposal on
Compulsory Slaughter of the Offspring of
BSE Cases
3.                " 22-23 January 1998 Defining the BSE risk for specified
geographical areas
4. Scientific Committee on
Veterinary Measures relating to
Public Health
17 February 1998 Safety of slaughter practices and methods:
risk of spread of BSE infectivity through
cross contamination of different tissues by
using pneumatic stunning during the
slaughter process of ruminants
5. Scientific Steering Committee 19-20 February 1998 Opinion on the revised version of the UK
Date Based Export Scheme and the UK
proposal on compulsory slaughter of the60
offspring of BSE cases, submitted on
27.01.98 by the UK Government to the
European Commission
6.              " " Final opinion on the contents of a
"Complete dossier of the epidemiological
status with respect to TSEs"
7.              " 26-27 March 1998 BSE risk
8.              " " Safety of Gelatine
9.              " " Safety of Tallow
10.            " " Safety of Meat and Bone Meal
11.            " 25-26 June 1998 The safety of dicalcium phosphate
precipitated from ruminant bones and used
as an animal feed
12.            " " Possible links between BSE and
organophosphates used as pesticides
against ecto- and endoparasites in cattle
13. Scientific Committee on
Medicinal Products and Medical
Devices
16 September 1998 Equivalency of alternative products to
intestines of animal origin for use as
surgical sutures
14. Scientific Committee on
Cosmetic Products and Non-Food
Products
23 September 1998 Updating of the opinion on the safety of
tallow derivatives
15. Scientific Steering Committee 24-25 September
1998
Risk of infection of sheep and goats with
BSE agent
16.            " " Mammalian derived meat and bone meal
forming a cross-contaminant of animal
feedstuffs
17.            " " Safety of organic fertilisers derived from
mammalian animals
18.            " " Updated Scientific Report on the safety of
meat and bone meal derived from
mammalian animals fed to non-ruminant
food-producing farm animals, prepared by
the Working Group
ANNEX 16
LIST OF ABBREVIATIONS USED
Abbreviation Meaning
ACDP Advisory Committee for Dangerous Pathogens
BABS (Animals) born after the ban61
BSE Bovine spongiform encephalopathy
CJD Creutzfeldt-Jakob disease
CPMP Committee for Proprietary Medical Products
DBES Date Based Export Scheme
DNA Desoxyribonucleic acid
FVO Food and Veterinary Office
IOE International Office of Epizootics
JRC Joint Research Centre
MAFF Ministry of Agriculture, Fisheries and Food
MBM Meat and bone meal
MECU ECU million
MRM Mechanically recovered meat
NFU National Farmers Union
SEAC Spongiform Encephalopathy Advisory Committee
SRM Specified risk materials
SSC Scientific Steering Committee
SVC Scientific Veterinary Committee
SVC Standing Veterinary Committee
TSE Transmissible spongiform encephalopathy
WHO World Health Organisation
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–  specified risk materials (SRM): §§ 28-46 ff - §§ 80-81
–  sporadic ("sporadic"cases): §§ 6-11-19
–  Surveillance Unit: § 20
–  tallow: §§ 37-80-81
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–  vertical transmission of BSE: § 11
–  veterinary control: § 43